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Abstract 
Prolonged exercise-heat-stress impairs both exercise performance and cognitive 
function. Military based operations are often performed in hot environmental 
conditions and thus performance and safety may be compromised which could be 
potentially life threatening. Acute ingestion of tyrosine (TYR), a catecholamine 
precursor, has been shown to improve aspects of cognitive function and mood during 
exposure to stressful environments, in military and sport specific settings. Currently, 
there is limited research exploring the optimal dose of TYR relative to blood values, 
to prescribe pre-exercise or before exposure to a stressor.  
 
Therefore, the purpose of experimental chapter 1 was to investigate the effects of 
acute TYR ingestion strategies (0, 150 and 300 mg.kg body mass-1 TYR administered 
in 2 equal doses, 4 h apart) on serum TYR concentrations at rest. Twenty-one healthy 
males were randomly allocated to one of three groups (n = 7 per group); HIGH (300 
mg.kg body mass-1 TYR in total), LOW (150 mg.kg body mass-1 TYR in total) and 
CON (sugar free squash placebo). Ingestion of TYR was double blinded and was 
administered in a drink form (dissolved in 250 mL sugar free squash) in two separate 
doses at both 0900 and 1300. Participants consumed a standardized breakfast (0800) 
and lunch (1200) prior to consumption of TYR and remained in the laboratory from 
0900-1700 having blood drawn every hour from a cannula. Measures of gastric 
discomfort were also recorded. Significant differences in serum TYR concentrations 
were observed between groups (p < 0.001), with the HIGH dose (399 ± 69 μmol/L) 
resulting in the largest elevation compared to the LOW dose (279 ± 76 μmol/L) and 
CON (64 ± 11 μmol/L). Ingesting TYR as a double-dose did not significantly increase 
the peak in serum TYR compared to the first dose in both groups; LOW (221 vs 279 
μmol/L) and HIGH dose (350 vs 399 μmol/L) (p > 0.05). No significant differences in 
gastric discomfort were observed between groups (p > 0.05). This study demonstrates 
that ingestion of a single dose of 150 mg.kg body mass-1 TYR may be sufficient to 
elevate serum TYR concentrations and that the peak in TYR concentration typically 
occurs 2 h post ingestion (without the need for a second identical dose 4 h later). 
 
Experimental chapter 2 was designed to investigate the effects of TYR ingestion on 
steady state exercise, cognitive function and time-trial performance in the heat, 
 xi 
utilising the identified dose from the findings of experimental chapter 1. Eight 
recreationally active, healthy males visited the laboratory on four occasions (two 
familiarisation and two experimental conditions). In a double-blind, counter-balanced, 
crossover design participants ingested a placebo [PLA (250 mL sugar free squash)] or 
TYR (same as PLA plus 150 mg.kg body mass-1 TYR powder) 1 h pre-exercise. 
Participants completed a 60 min walk at 6.5 km.h, followed by a 2.4 km time-trial 
carrying a 25 kg backpack in 40°C; 30% RH. Cognitive function (vigilance, dual-task 
and simple reaction time) was assessed at 5 time-points; pre-ingestion, pre-exercise, 
30 min into exercise, post 60 min exercise and post time-trial. Traditional 
physiological (HR), perceptual (RPE, TSS) and temperature (rectal and skin 
temperature) measures were recorded throughout exercise. A significant increase from 
pre-post exercise (p < 0.01) was observed for vigilance and dual-task FALSE scores, 
and for reaction time in both conditions. However, no significant difference was 
observed between TYR and PLA conditions in any of the cognitive tests measured (p 
> 0.05). Furthermore, no significant difference was observed in time-trial completion 
time (F1,14 = 547.9 , p = 0.74) between TYR (19.78 ± 3.44 min) and PLA (20.29 ± 
3.55 min). No significant differences were observed in any of the physiological, 
perceptual or temperature measures between conditions (p > 0.05). 
 
The main findings presented within this thesis indicate that although it was identified 
that a single dose of 150 mg.kg body mass-1 was sufficient to significantly elevate 
serum TYR concentrations, ingestion of this dose did not influence cognitive function 
or time-trial performance in the heat. This is surprising since ingestion of similar 
doses have significantly improved aspects of cognitive function previously during 
exercise-heat-stress. In conclusion it appears that under the conditions of the present 
study, TYR is not a useful ergogenic aid. Future research should aim to elucidate the 
central effects of TYR to enable a better understanding of its mechanistic properties. 
 
Key words: Heat-stress; central fatigue; tyrosine; cognitive function 
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CHAPTER 1: General Introduction  
Exposure to extreme stressors can impede an individual’s capability to perform both 
physical (González-Alonso et al., 1999) and cognitive tasks (Banderet and 
Lieberman, 1989, Lane et al., 2004). Strenuous activities undertaken within extreme 
environmental conditions, such as high heat and humidity, impose an additional strain 
on the body, resulting in an accelerated and premature onset of fatigue (Nybo et al., 
2014). Fatigue is a complex phenomenon, defined as the inability to sustain a given 
workload (Nybo and Nielsen, 2001b) and is suggested to occur at all levels of the 
brain-muscle pathway (Roelands and Meeusen, 2010). Originally, fatigue was 
primarily attributed to a ‘metabolic endpoint’ involving endogenous substrate 
depletion and various other peripheral mechanisms (Meeusen et al., 2006b). 
However, it is now clear that there is also a significant involvement of the central 
nervous system (CNS), suggesting that both peripheral and central factors are 
implicated in fatigue development (Roelands and Meeusen, 2010, Nybo et al., 2014).  
 
Several theories exist to explain the notion of centrally mediated fatigue (Cheung and 
Sleivert, 2004), however the original ‘central fatigue hypothesis’ proposes that 
prolonged exercise and/or exposure to extreme stress alters the activity and synthesis 
of the central monoamines, serotonin (5-HT), dopamine (DA) and noradrenalin (NA) 
(Newsholme, 1987). An elevated ratio of brain DA:5-HT has been suggested to 
augment performance, whereas low ratios induce lethargy and losses in motivation 
(Davis and Bailey, 1997). Thus, DA and NA (converted from DA) are significant 
neurotransmitters involved in the execution of both physical and cognitive tasks due 
to their direct association with alterations in arousal, motivation and motor control 
(McMorris et al., 2006, Watson, 2008). This knowledge proffers the opportunity to 
manipulate the CNS using nutritional intervention strategies to attenuate the onset of 
fatigue in stressful environments. This may be useful in an athletic, occupational and 
military setting, as small dietary mediated improvements can significantly influence 
performance in physical and cognitive tasks (Meeusen et al., 2006a, Roelands and 
Meeusen, 2010, Baker, 2013, Meeusen, 2014).  
 
The precursor for catecholamine synthesis is tyrosine (TYR), a non-essential amino 
acid found in protein rich dietary sources and synthesised in the liver from 
 2 
phenylalanine (Wurtman et al., 1980). An exogenous source of TYR through oral 
supplementation increases the ratio of TYR to other large neutral amino acids 
(LNAA) for competitive transportation across the blood-brain-barrier (BBB), 
resulting in a greater cerebral uptake and an increase in DA and NA synthesis 
(Glaeser et al., 1979). Previous military research investigating the effects of TYR 
observed significant improvements in aspects of cognitive function during exposure 
to stressful environments such as cold (Banderet and Lieberman, 1989, Mahoney et 
al., 2007, O'Brien et al., 2007) and hypoxia (Banderet and Lieberman, 1989), 
extended wakefulness (Neri et al., 1995) and the physical/emotional stress nexus 
(Deijen et al., 1999). More recently, research has focused on the effect of TYR in an 
athletic population, finding improvements in exercise capacity (Tumilty et al., 2011) 
and cognitive function (Coull et al., 2015) after TYR ingestion in a warm 
environment. However, further investigations have failed to replicate these findings, 
despite implementing similar exercise paradigms and dose administration strategies 
(Watson et al., 2012, Tumilty et al., 2014). 
 
It appears that TYR ingestion has the potential to influence centrally mediated fatigue 
and possibly improve aspects of cognitive function, mood and exercise performance 
during acute stress (Meeusen, 2014). As many sporting events, military operations 
and occupational pursuits are performed in stressful environments, most commonly in 
hot conditions, the use of TYR may be beneficial. There is limited research examining 
the effects of TYR on performance (physical and cognitive) in a military/occupational 
based setting, specific to heat stress and thus further research is required in this area. 
Moreover, lack of data on the dose response of TYR restricts its use as a nutritional 
aid (Marriott and Thomas, 1994).  
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CHAPTER 2: Literature Review 
2.1 Thermoregulation and Heat-stress 
Humans are homoeothermic beings and constantly generate heat in all cells of the 
body as mechanical or thermal energy from metabolic activity (Cheung et al., 2000, 
Gonzalez-Alonso, 2012). The human body is able to regulate this heat production by 
maintaining a thermal balance between heat gain and heat loss, to achieve a stable 
deep body temperature of ~37°C (Havenith, 1999). This balance is sufficient for the 
basic functions of the body at rest in normothermic conditions and is effortlessly 
maintained via heat loss mechanisms to dissipate excess heat (Havenith, 1999). The 
four main pathways (radiation (Ṙ), conduction (Ċ), convection (K̇) and evaporation 
(Ė)) in which heat can be gained or lost can be defined in a simple heat balance 
equation, derived from the first law of Thermodynamics as follows: 
 
Ṡ = Ṁ ± Ẇk ± Ṙ ± Ċ ± K̇ - Ė (W.m-2) 
 
Where Ṡ represents heat storage, Ṁ represents metabolic heat production and Ẇk is the 
external work performed by the individual in question (Cheung, 2009). 
 
During exercise, the production of heat and consequential rise in core body 
temperature is detected by the thermo-sensitive neurons in the preoptic-anterior 
hypothalamus, which receive afferent sensory input from thermoreceptors located in 
the skin and internal organs (Wendt et al., 2007). These sensory signals are integrated 
within the hypothalamus, which allows for autonomic initiation of thermoregulatory 
responses appropriate for any given thermal stress (Wendt et al., 2007, Nakamura, 
2011). Typically, detection of increased body and brain temperature triggers a 
response whereby heat is transferred from the core to the skin down a temperature 
gradient and subsequently dissipated to the environment via cutaneous vasodilation 
and the above heat loss mechanisms (Cheung, 2009, Nybo et al., 2014). However, 
when ambient temperature is higher than skin temperature, the body begins to gain 
heat (resulting in a positive value for Ṡ in the above equation) from the environment 
and therefore evaporation becomes the primary method of heat loss (Havenith, 1999). 
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Heat is lost as sweat evaporates from the skins surface, which subsequently cools the 
blood below, accounting for a large proportion of heat dissipation (Brotherhood, 
2008). This mechanism is dependent upon the relative humidity (RH) of the 
environment as this alters the water vapour pressure gradient between the 
environment and the body. Thus if humidity is high, skin cooling via sweat 
vaporisation is reduced and as a consequence, heat production surpasses the capacity 
for heat loss, leading to an elevated body and brain temperature (Wendt et al., 2007). 
Additionally, wearing clothing and protective garments will further compromise 
evaporative heat loss by impeding the natural movement of water vapour, 
consequently exacerbating the rate of heat gain to potentially dangerous levels 
(Havenith, 1999, Cheung, 2009). 
 
2.2 Hyperthermia-induced Fatigue 
A significant rise in body and brain temperature due to inadequate thermoregulation 
(hyperthermia) is associated with physiological and cellular dysfunction, heat 
exhaustion and if left untreated, may result in death (Hocking et al., 2001, Cheung 
and Sleivert, 2004). It is difficult to distinguish between the effects of a high body 
temperature and that of a high brain temperature within the literature, as brain 
temperature is not easily measured during physical exercise. It has been suggested 
that brain temperature increases in parallel with that of core temperature during 
exercise. However, there is evidence to show that on average, the brain is slightly 
warmer (by 0.2-0.3°C) than the core due to its higher heat production and inadequate 
heat release (Nybo et al., 2002), therefore this must be taken into account.  
 
Heat induced fatalities (caused by high internal temperatures) are known to occur in 
athlete and military populations, whereby individuals push themselves to physical 
exertion during training and competitions in hot conditions (Gaoua et al., 2011, 
Epstein et al., 2012). Heat-stress exacerbates the development of fatigue (defined as 
the inability to maintain work at a given intensity) and thus performance in physical 
and cognitive tasks deteriorates at a faster rate than in temperate conditions (Nybo et 
al., 2014). This early onset of fatigue is suggested to be a result of the complex 
interplay between various central and peripheral factors (Cheung and Sleivert, 2004, 
Nybo et al., 2014). Understanding these factors and mechanisms and the way in 
which they are implicated in the fatigue process is crucial in the successful 
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development of interventions strategies to offset premature fatigue and alleviate heat-
induced performance decrements. In a recent review, Nybo et al. (2014) present a 
detailed model illustrating how these factors integrate and collectively influence 
fatigue and ultimately performance (Figure 2.1). The present literature review will 
focus only on the relevant central, peripheral and psychological factors within this 
model.   
 
 
 
Figure 2.1. Integrative model incorporating cardiovascular, respiratory, CNS and 
peripheral factors that may contribute to exercise-induced fatigue in the heat (Nybo et 
al., 2014). 
  
 
2.3 Peripheral Aspects of Fatigue 
Historically, the development of fatigue was primarily associated with peripheral 
factors, specifically the occurrence of a ‘metabolic endpoint’ (Meeusen et al., 2006b). 
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These factors include, but are not limited to, substrate depletion, accumulation of 
metabolic by-products, adverse peripheral effects of hypohydration and an elevated 
core temperature (Roelands and Meeusen, 2010). These factors, individually and 
collectively contribute to the development of fatigue and thermal strain in both 
temperate and hot environments. However, as fatigue can arise without any signs of 
muscular dysfunction or inadequate availability of substrate, it is believed that 
mechanisms within the CNS are also implicated in the fatigue process (Foley and 
Fleshner, 2008). Therefore, fatigue should be acknowledged as ‘complex 
phenomenon’ occurring at all levels of the brain-muscle pathway (Roelands and 
Meeusen, 2010, Nybo et al., 2014). 
 
2.4 Central Fatigue 
Centrally mediated fatigue has become a topic of interest over recent decades with 
several theories being suggested to elucidate the possible mechanisms involved (Nybo 
et al., 2014). Alterations in cerebral temperature, perceived effort, motivation and 
monoamine neurotransmission are all suggested to be mechanistically associated with 
central fatigue in normal and hot environments (Foley and Fleshner, 2008). However, 
a specific definitive cause has not yet been discovered. 
 
2.4.1 Critical Core Limit 
It has long been recognised that a high core and brain temperature influence the 
ability and drive to continue exercising. Over recent years it has been demonstrated 
that voluntary exhaustion in the heat occurs at similar and consistent core body 
temperatures in humans (~39-40°C) (Gonzalez-Alonso et al., 1999, Nybo and 
Nielsen, 2001a, Cheung and Sleivert, 2004). It is proposed that the notion of central 
fatigue is a protective mechanism against the attainment of a critically high core and 
brain temperature (~40°C), to prevent heat stroke and cell damage/death (Nielsen and 
Nybo, 2003, Nybo et al., 2014). It has been suggested that above this ‘critical core 
limit’, humans are unable to continue exercising and thus a high internal temperature 
is considered the main limiting factor of performance in hot environments (Gonzalez-
Alonso et al., 1999). However, this theory should not be misconceived as if 
exhaustion/fatigue is dictated by a ‘critical core temperate’ threshold (Nybo et al., 
2014). Previous studies have demonstrated that pharmacological manipulation of DA 
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and administration of caffeine allows individuals to surpass this set ‘limit’ reaching 
higher core temperatures (~0.5°C) when exercising in the heat (Watson et al., 2005a, 
Cheuvront et al., 2009, Roelands and Meeusen, 2010, Nybo, 2012, Nybo et al., 2014). 
Moreover, in competitions and training when athletes and military personnel are 
highly motivated and pushed to their limits, dangerously high core temperatures have 
been reached, exceeding those observed in laboratory conditions (Ely et al., 2009, 
Epstein et al., 2012). It is also evident that highly trained individuals are able to 
tolerate higher core temperatures (~39-40°C) before voluntary exhaustion, compared 
to their untrained counterparts (~38-39°C) (Cheung and Sleivert, 2004). Therefore, it 
is clear that core temperature is not solely responsible for hyperthermia-induced 
central fatigue and several other mechanisms within the CNS may also contribute to 
the fatigue response. 
 
2.4.2 Neurotransmitter Systems 
Several research groups have explored the theory that altered brain neurotransmitter 
concentrations may contribute to the fatigue process during exercise-heat-stress 
(Watson et al., 2004, Hasegawa et al., 2008, Roelands et al., 2008, Roelands and 
Meeusen, 2010). It is recognised that specific monoamines can influence 
thermoregulation and that alterations in brain concentrations/ratios of 5-HT, DA and 
NA may play a key role in the premature onset of fatigue in hot environments 
(Roelands et al., 2009, Meeusen and Roelands, 2010, Roelands and Meeusen, 2010).  
 
2.4.2.1 The ‘Central Fatigue Hypothesis’ 
Early links to the role of 5-HT and DA in centrally mediated fatigue initiated the 
development of the first neurotransmitter related theory, the ‘central fatigue 
hypothesis’ (Acworth et al., 1986, Newsholme, 1987). This hypothesis is based on the 
concept that during prolonged exercise, the activity and synthesis of the central 
monoamines (5-HT, DA and NA) are altered (Meeusen et al., 2006b). Specifically, it 
is suggested that increases in brain serotonergic activity during exercise may induce 
lethargy, losses in motivation and decreased mental alertness, consequently resulting 
in performance decline (Newsholme, 1987). An increase in brain 5-HT concentration 
is brought about by elevations in blood fatty acids during prolonged exercise as this 
promotes increases in free tryptophan, a precursor to 5-HT (Roelands and Meeusen, 
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2010). As tryptophan competes with branched-chain amino acids (BCAA) for 
transport through the BBB, an increased ratio favours the entry of tryptophan, which 
is then synthesised to 5-HT leading to higher brain concentrations (Meeusen et al., 
2006b). Despite the plausible theory behind the central fatigue hypothesis, evidence to 
support the role of 5-HT in centrally mediated fatigue in the heat is limited in humans 
(Roelands and Meeusen, 2010, Nybo et al., 2014). Although, it is possible that 
dysregulation of 5-HT may act on other CNS systems (such as the dopaminergic 
system), indirectly influencing the development of fatigue during exercise (Meeusen 
et al., 2006b, Nybo, 2010). 
 
2.4.2.2 Dopamine and Central Fatigue 
Several research groups have since challenged the original central fatigue hypothesis 
with the theory that dopaminergic activity and the interaction between brain 5-HT and 
DA also play an important role in CNS fatigue (Foley and Fleshner, 2008). As DA is 
associated with arousal, motivation, reward and attention, its involvement in central 
fatigue becomes obvious (Meeusen et al., 2006b). The first links to DA in central 
fatigue came from early work on animals, demonstrating increases in dopaminergic 
activity during prolonged exercise (Bliss and Ailion, 1971), which may be relevant to 
physical and cognitive performance (Davis and Bailey, 1997). Furthermore, 
manipulation of brain DA concentrations with certain drugs (e.g. amphetamines) 
confirmed its involvement in the development of exercise-induced central fatigue 
(Gerald, 1978, Heyes et al., 1985). Thus, on the basis of such observations, 
Newsholme’s original ‘central fatigue hypothesis’ was adapted by Davis and Bailey 
(1997) to include the influence of DA. The revised hypothesis proposes that an 
increased brain ratio of 5-HT:DA is related to feelings of lethargy and tiredness, 
accelerating the fatigue process, while low ratios augment performance by preserving 
levels of motivation and arousal (Davis and Bailey, 1997).  
 
Dopaminergic cells located in the mid-brain are the main source of DA within the 
CNS, found in the pars compacta region of the substantia nigra of the brain (Foley 
and Fleshner, 2008). The nigrostriatal pathway, involving cell bodies in the substantia 
nigra and striatum, is implicated in motor control and movement. Another important 
pathway is the mesocortical pathway, which connects the ventral tegmental area to the 
prefrontal cortex and is involved in normal cognitive control, motivation and 
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behavioural responses (Savitz et al., 2006). Both the striatum and prefrontal cortex 
require dopaminergic projections to function and thus if DA synthesis is limited, 
declines in cognitive function will occur (Cools, 2008). The rate-limiting step in the 
biosynthesis of DA (and NA) is the hydroxylation of the amino acid TYR. As DA 
cannot readily cross the BBB, neurons must synthesis it in the brain themselves and 
the rate of synthesis depends upon the availability of TYR, a DA precursor (Foley and 
Fleshner, 2008). To enter the brain, TYR must compete with other LNAA, including 
tryptophan, to cross the BBB as they share the same transporter system (Cools, 2008). 
On reaching the presynaptic neuron, TYR is oxidised and converted to L-3-4-
dihydroxyphenylalanine (L-Dopa) by the rate-limiting enzyme TYR hydroxylase. L-
Dopa is subsequently decarboxylated via L-aromatic amino acid decarboxylase to 
form DA (Foley and Fleshner, 2008). In neurons that utilise DA as a transmitter, no 
further enzymatic pathways occur; however, neurons that use NA as a transmitter 
require an extra step to convert DA to NA via the enzyme DA-β-hydroxylase 
(Fernstrom and Fernstrom, 2007). Figure 2.2 provides a diagrammatic portrayal of the 
TYR to DA synthesis pathway.  
 
 
Figure 2.2. Simplified illustration of the competitive transport of TYR into the brain 
and the DA synthesis pathway in the presynaptic neuron. *Rate limiting enzyme 
tyrosine hydroxylase converts TYR to L-DOPA. DA is then metabolised to 
dihydroxyphenylacetic acid (DOPAC) and can be further catabolised to homovanillic 
acid (HVA) (Fernstrom, 2013). 
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After the conversion of TYR to DA through the above pathway, DA is released from 
the presynaptic terminal to activate G protein-coupled DA receptors (namely D1 and 
D2 class). Activation of these receptors occur from the binding of DA after it a crosses 
the inter-synaptic space (Cropley et al., 2006). D1 class receptors (D1 and D5) 
stimulate cyclic adenosine monophosphate (cAMP) production by adenylyl cyclase 
and are located postsynaptically on DA receptor cells. Whereas the D2 class receptors 
(D2, D3 and D4) induce inhibition of adenylyl cyclase and are expressed both 
postsynaptically (DA target cells) and presynaptically (DA neurons). In the brain, D1 
and D2 receptors are expressed in both the striatum and frontal cortex (Beaulieu and 
Gainetdinov, 2011).  
 
As previously discussed, during prolonged exercise, particularly in high ambient 
temperatures, there is a specific demand for DA to enable the maintenance of arousal, 
motivation (drive to continue exercise) and motor control. Initially, catecholamine 
synthesis and release is increased during stress (e.g. exercise and or/heat-stress) 
(Lieberman et al., 2005). However, as exercise continues and exhaustion begins to 
occur, there is a marked decrease in central DA concentration (Wurtman et al., 1980), 
therefore suggesting that depletion of central catecholamines may be associated with 
fatigue and performance in the heat (Bailey et al., 1993, O'Brien et al., 2007). This 
has been confirmed in animal models (rodents) as central DA depletion was shown to 
accelerate exhaustion, while an increase in dopaminergic activity prolonged time to 
exhaustion (Heyes et al., 1985). Furthermore, a follow up study observed no influence 
of striatal DA depletion on exercise performance in the first 40% of an exhaustion 
run, however performance rapidly deteriorated during the latter 60% (Heyes et al., 
1988). These results indicate that during the latter stags of exercise, when exhaustion 
is imminent, there is a need to increase DA activity to improve exercise performance 
(Meeusen and Demeirleir, 1995). 
 
2.4.2.3 Other Factors Influencing Central Fatigue 
The notion of central fatigue is multifaceted and complex and there are various other 
factors that may influence the fatigue process. Not all of these factors have been 
explored in great detail and thus it is difficult to ascertain their exact contribution to 
central fatigue. Aside from the influence of the specific monoamines previously 
discussed, other neurotransmitters may also be involved in the fatigue process. 
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Gamma-aminobutyric acid (GABA) and glutamate have each been suggested to have 
a small involvement in the development of central fatigue (Meeusen et al., 2006a). 
Glutamate is suggested to be the main excitatory neurotransmitter and GABA is the 
main inhibitory neurotransmitter in the mammalia cortex and thus have both been 
associated with exercise and central fatigue (Guezennec et al., 1998). Another 
excitatory neurotransmitter that has been implicated in the fatigue process is 
acetylcholine. The synthesis, release and reuptake of acetylcholine is fundamental in 
the generation of muscular force and its association with memory, awareness and 
thermoregulation highlights its probable link with central fatigue within the CNS 
(Davis and Bailey, 1997). Furthermore, it is suggested that adenosine plays a role 
within the development of central fatigue as it inhibits the release of excitatory 
neurotransmitters such as DA and NA, consequently reducing arousal. The 
relationship between adenosine, caffeine and fatigue will be discussed in 2.6.2. 
 
Another area of CNS fatigue that has received little attention is the BBB and how 
changes in its integrity may influence the fatigue process. The BBB is generally 
resistant to changes in permeability, however in some circumstances its function may 
be acutely or chronically compromised resulting in a disturbance of its mechanistic 
properties (Meeusen et al., 2006a). To support this statement, there is evidence that 
prolonged exercise in a warm environment results in an increase in BBB permeability 
in humans (Watson et al., 2005b). One factor that may contribute to increased BBB 
permeability is increased levels of ammonia that occur during exercise, which also 
influences cerebral levels of GABA and glutamate (Davis and Bailey, 1997). 
Furthermore, insulin plays a major regulatory role in the CNS and has several effects 
on barrier cell function (Banks et al., 2012). Insulin enhances the transport of the 
amino acids TYR and tryptophan from the blood to the brain indirectly, by reducing 
the levels of the other BBB competing amino acids (Tagliamonte et al., 1976). This 
results in an increased brain concentration of either TYR or tryptophan and thus may 
potentially influence central fatigue. Each of the factors outlined above may each 
influence the central fatigue process, however, the extent to which is currently 
unknown (Meeusen et al., 2006a). 
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2.5 Heat-stress and Performance 
As previously mentioned in section 2.2 of this review, prolonged exposure to hot 
environmental conditions impairs performance in both physical and cognitive tasks. 
Optimal performance (physical and cognitive) is of great importance to athletes and 
military personnel alike and even small decrements could significantly alter the 
outcome of competitions and military operations and in extreme circumstances, could 
be life threatening. A plethora of research has investigated the effects of heat-stress on 
exercise performance, whereas its effects on cognitive function have received 
significantly less attention (Hocking et al., 2001). 
 
2.5.1 Physical Performance 
During physical activity in hot environments, the combination of endogenous heat 
production and exogenous heat-stress deteriorate performance. According to Nybo et 
al. (2014), this impairment is observed during both high-moderate intensity exercise 
and fixed and self-paced exercise and was present in 23 of the 24 studies examined 
within their review. Specific studies directly investigating the influence of heat-stress 
on exercise performance share comparable observations. For example, it has been 
demonstrated that high ambient temperatures (31°C) can reduce the capacity to 
perform prolonged physical exercise by ~50% when compared to a cooler 
environment (11°C) (Galloway and Maughan, 1997). Similarly, Tatterson et al. 
(2000) observed a 6.5% reduction in power output during a 30 min cycling time-trial 
in the heat (32°C), accompanied by a significant increase in skin temperature and 
sweat rate. Interestingly, core temperature was similar in both the hot and temperate 
condition in this investigation (23°C). More recently, performance in a pre-loaded 
time-trial (15 min) decreased as subjects covered less distance in the hot (30°C) 
compared to moderate condition (14°C) (Tyler and Sunderland, 2008). Furthermore, 
it has been shown that as environmental temperature increases there is usually a 
subsequent increase in rating of perceived exertion and thermal sensation for the 
exercise/task completed (Maw et al., 1993, Nybo and Nielsen, 2001b). This supports 
the notion that internal temperature is not the only factor to influence fatigue in the 
heat as alterations in the subjective state of the individual may also play a part. It is 
suggested that the ‘drive’ to continue exercising is influenced by central mechanisms 
and is associated with exhaustion in the heat (Roelands and Meeusen, 2010). 
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In summary, it is clear that heat-stress (25-40°C) impairs exercise performance during 
a diverse range of exercise tasks (time-trial, exercise to exhaustion, pre-loaded 
exercise) and modes (cycling, treadmill running). Higher ambient temperatures and 
humidity have an exacerbated negative impact on performance as fatigue develops at 
an accelerated rate. Knowledge of the various mechanisms that influence fatigue has 
enabled the development of intervention strategies to alleviate heat-induced 
decrements in performance which are of great interest to athletes and individuals 
undertaking occupational tasks in extreme environments (Watson, 2008).  
 
2.5.2 Cognitive Function 
As previously discussed, exercise-heat-stress results in a number of physiological, 
thermal and perceptual changes, which may deter performance in cognitive tasks.  
However, compared to the physiological effects of heat-stress, its impact on cognitive 
function is not well understood (Hocking et al., 2001, Gaoua, 2010). From the current 
literature, it is difficult to compare findings from previous studies assessing cognitive 
function due to the various different experimental designs employed (Gaoua, 2010). It 
is suggested that factors such as the type and complexity of the cognitive test, severity 
of heat exposure (temperature, duration), protocol design (passive or active heat-
stress) and prior experience of the individual each influence the outcome measures 
and thus a complete systemic review of the literature is not possible (Hancock and 
Vasmatzidis, 2003, Gaoua et al., 2011). This review will mainly focus on exercise-
heat-stress (active heat exposure) based assessments of cognitive function. 
 
Acute exercise (low-moderate intensity) has been shown to improved performance in 
both simple and complex cognitive tasks (Chmura et al., 1998, Collardeau et al., 
2001), suggested to result from increases in arousal, cerebral blood flow and 
neurotransmitter release, occurring at the onset of exercise (Grego et al., 2004). 
Therefore, it is possible that studies using exercise-heat-stress designs to induce 
hyperthermia-related fatigue may actually be blunting the negative effects of heat 
through the beneficial effects of exercise (Gaoua, 2010). However, this may not apply 
to prolonged exercise-heat-stress, which has been shown to impair cognitive function 
due to the fatiguing effects of both prolonged heat exposure (30-40°C) and long-
duration exercise (Cian et al., 2001, Hocking et al., 2001, Bandelow et al., 2010, 
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Watson et al., 2012). Thus, the effect of exercise on cognitive function is dependent 
upon the magnitude of stress imposed on the individual. 
 
Previous studies have utilised a wide variety of cognitive tasks with differing 
complexities, which adds to the difficulty in comparing and understanding findings in 
this area (Gaoua, 2010). It is generally accepted that heat-induced cognitive declines 
are task dependent, as complex tasks (i.e. working memory, vigilance, dual-task) are 
typically affected more by heat-stress than simpler tasks (i.e simple reaction time) 
requiring less attention (Hancock and Vasmatzidis, 2003, Gaoua, 2010, Gaoua et al., 
2011). This is supported by previous exercise-heat-stress studies in which decrements 
were observed in certain aspects of cognitive function but not others. For example, 
Watson et al. (2012) observed a significant increase in error rate during the complex 
component of the Stroop test after cycling to exhaustion in a hot environment (30°C; 
50% RH); however reaction time and rapid visual information processing were not 
influenced. Furthermore, two studies demonstrated declines in other complex aspects 
of cognitive function (working and long term memory) after exercising in the heat 
(45-50°C and 35°C respectively) (Cian et al., 2001, Hocking et al., 2001). Similarly, a 
recent well-controlled, passive heat investigation found significant impairments in 
working memory without any alterations in simple attentional processes after 
exposure to extreme heat (50°C) and thus concluded that the effects of hyperthermia 
on cognitive function are task dependent (Gaoua et al., 2011). 
 
The mechanisms by which heat-stress impairs cognitive function are not completely 
clear, thus recent studies have attempted to elucidate this with the use of more direct 
measurements of brain function (Gaoua, 2010). Various brain imagining techniques 
have been utilised in relation to heat-stress, such as functional magnetic resonance 
imaging (fMRI) (Liu et al., 2013), electroencephalography (EEG) (Hocking et al., 
2001, Sun et al., 2011, Kishore et al., 2013) to reveal functional areas of the brain 
responsible for specific cognitive processes. However, many of the studies utilising 
such advanced techniques were conducted during passive heat-stress due to the 
difficulty implementing these tools during exercise. One exercise-heat-stress study 
employed a specific EEG paradigm referred to as steady-state probe topography 
(SSPT), which can highlight the different relationships of the brains electrical 
activities during completion of cognitive tasks using steady-state visually evoked 
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potentials (Hocking et al., 2001). Under thermally stressful conditions they observed 
increased amplitude and decreased latency in the frontal and occipitoparietal regions 
of the brain, indicating greater use of the neural resources to sustain performance in 
the heat. Additionally, Nielsen et al. (2001) investigated the EEG activity of the 
frontal cortex during exercise in the heat and observed an increase in activity at the 
onset of exercise, followed by supressed arousal in the hot conditions compared to 
control. This suggests that electrical activity alterations in the brain’s frontal cortex 
occurred as a result of hyperthermia-induced fatigue (Nielsen et al., 2001, Gaoua, 
2010). 
 
Although the evidence is not entirely clear due to methodological variances, it appears 
that exercise-heat-stress negatively affects cognitive function, especially performance 
in complex tasks (Hocking et al., 2001, Hancock and Vasmatzidis, 2003, Gaoua, 
2010). A variety of factors influence cognitive processes during exercise-heat-stress, 
hence there is no stand-alone mechanism reported in the literature. An increase in 
internal temperature is suggested to alter electrical activity within certain brain 
regions, suppressing arousal levels (Nielsen et al., 2001). Elevations in skin 
temperature (~3°C) have also been shown to influence cognitive function by altering 
the subjective state of individuals and increasing sensory displeasure (Gaoua et al., 
2012). Furthermore, as previously mentioned, alterations in the activity and synthesis 
of central monoamines, namely DA, NA and 5-HT, may induce declines in cognitive 
function due to their association with motor control and alertness. Specifically, as 
previously mentioned, exercise in the heat demands a constant supply of DA to 
maintain levels of motivation, arousal and motor control, compared to temperate 
conditions (Meeusen, 2014). Each of these factors play a role in hyperthermia-
induced fatigue and contribute to cognitive decline during exercise-heat-stress (Nybo 
et al., 2014), therefore interventions strategies that can alleviate such declines may be 
beneficial to performance. 
 
2.6 Nutritional Manipulations  
Events arising entirely within the CNS can influence fatigue (Watson, 2008) as 
described in sections 2.4.2 and 2.5.2. Alterations in the ratio of 5-HT:DA is 
implicated in the fatigue process, with high ratios inducing lethargy and motivation 
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losses and low ratios favouring performance improvements (Meeusen et al., 2006b). 
This knowledge proffers the opportunity to manipulate the CNS in favour of 
enhanced performance with the use of nutritional interventions strategies (Roelands 
and Meeusen, 2010). Dietary mediated improvements may be beneficial to 
individuals working and exercising in hot environments for performance and safety 
purposes, hence the efficacy of numerous nutrients and supplements have been 
assessed, namely BCAA, carbohydrates, caffeine and TYR (Watson, 2008). Table 2.1 
provides an overview of the neurotransmitters involved in the development of fatigue 
and the proposed effect of specific nutritional supplements used to manipulate them, 
which will be discussed in detail in further sections. 
 
 
 
 
2.6.1 Manipulation of 5-HT 
Many previous studies have attempted to manipulate central levels of 5-HT with 
supplementation of specific nutrients, such as amino acids (BCAA) and carbohydrates 
(Meeusen et al., 2006b, Fernstrom, 2013). Ingestion of both BCAA and carbohydrates 
are suggested to lower the ratio of free tryptophan:BCAA (via an increase in plasma 
BCAA availability and suppression of lipolysis respectively), which reduces its 
Neurotransmitter Role(s) Manipulation 
Serotonin (5-HT) Involved in feelings of tiredness, lethargy 
and sleep. Also influences pain, appetite 
regulation and thermoregulation 
 
Tryptophan: ↑ 5-HT 
BCAA: ↓ 5-HT 
Carbohydrate: ↓ 5-HT 
Dopamine (DA) Plays an important role in motivation, 
memory, reward, attention and motor 
control and thermoregulation 
 
TYR: ↑ DA 
BCAA: ↓ DA (?) 
Noradrenaline (NA) Involved in the regulation of attention, 
arousal and also learning and memory, 
anxiety, pain and mood 
 
TYR: ↑ NA 
BCAA: ↓ NA (?) 
Adenosine Acts as both a neurotransmitter and a 
neuromodulator and is able to inhibit 
excitatory neurotransmitters, namely DA 
and NA 
Caffeine: ↓ adenosine 
Table 2.1. Overview of the main neurotransmitters involved in the fatigue process and the 
nutritional supplements used to manipulate them. Adapted from Watson (2008).  
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transport across the BBB, thus limiting 5-HT synthesis in the brain (Davis et al., 
1992, Meeusen et al., 2006b). It is hypothesised that reducing cerebral 5-HT 
concentrations will attenuate feelings of fatigue and enhance performance (Table 2.1). 
However, despite the plausible mechanism for the use of such nutrients, there is 
limited evidence to support this, especially in hot environments (Meeusen, 2014). 
Specifically, BCAA ingestion did not improve time to exhaustion (Watson et al., 
2004), time-trial performance (Cheuvront et al., 2004) or cognitive function 
(Mittleman et al., 1998, Cheuvront et al., 2004) after moderate intensity exercise in 
the heat (30-40°C). A possible explanation for the failure to observe a benefit from 
BCAA ingestion may be related to its influence on DA synthesis. Administration of 
exogenous BCAA not only attenuates the rise in brain 5-HT but also reduces the 
uptake of TYR, which limits the synthesis and release of DA (Watson, 2008). 
Therefore, the negative effects associated with a decline in DA (Table 2.1) may 
counteract the positive effects of reducing 5-HT, consequently having no influence on 
physical or cognitive performance (Fernstrom, 2013). It is likely that this effect could 
be eradicated if the BCAA mixture also contained appropriate amounts of TYR, 
however this is yet to be investigated. 
 
2.6.2 Manipulation of DA 
Other research has focused on the nutritional manipulation of DA in an attempt to 
attenuate central fatigue and improve performance in physical and cognitive tasks 
(Table 2.1). Caffeine has been investigated due to its central effects as an adenosine 
antagonist whereby caffeine binds to adenosine receptors, blocking its activity and 
sedative-like action (Watson, 2008). Adenosine is capable of inhibiting the release of 
the excitatory neurotransmitters (DA and NA), thus ingestion of caffeine results in 
elevations in central DA and NA (Meeusen, 2014). However, evidence for a 
beneficial effect of caffeine during exercise in the heat is currently limited. A recent 
study demonstrated a ‘worthwhile’ improvement in cycling time-trial performance in 
a hot environment after administration of caffeine (35°C; 25% RH) (Pitchford et al., 
2014), whereas previous studies have reported no effect in similar environments on 
exercise performance (Cheuvront et al., 2009, Roelands et al., 2011) and cognitive 
function (Zhang et al., 2014). 
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2.6.2.1 Tyrosine 
The dietary precursor for catecholamine synthesis (DA and NA) is TYR, a non-
essential amino acid contained within protein rich dietary sources and synthesised in 
the liver from phenylalanine (Wurtman et al., 1980). Ingestion of exogenous TYR 
increases its ratio to other LNAA (including tryptophan) for competitive transport 
across the BBB (Figure 2.2), thus resulting in a greater cerebral uptake and an 
increase in DA synthesis in the brain (Fernstrom and Faller, 1978, Gibson and 
Wurtman, 1978). The synthesis of TYR to DA is controlled by a rate-limiting step, 
the conversion of TYR to L-DOPA via the enzyme TYR hydroxylase, as explained 
previously in section 2.4.2.2.  
 
Under normal conditions in the absence of stress, levels of TYR hydroxylase are 
apparently saturated with substrate, thus exogenous supply of TYR should not in 
theory influence catecholamine synthesis in the brain (Foley and Fleshner, 2008). 
However, during periods of acute or chronic stress, catecholamine turnover is up-
regulated with observed elevations in concentrations of catecholamine 
neurotransmitters in several brain regions including the striatum and hypothalamus of 
rodents (Lehnert et al., 1984, Meeusen et al., 1997, Foley and Fleshner, 2008). As 
more neurotransmitters are synthesised to meet the demands of the specific stressor, 
the precursor TYR is expended and thus availability becomes low (Jongkees et al., 
2015). At the point of exhaustion, brain tissue DA content is markedly decreased and 
thus it is acknowledged that depletion of brain catecholamines and TYR availability 
influences stress-induced fatigue (Bailey et al., 1993, O'Brien et al., 2007). 
 
As the synthesis of DA and NA in the brain relies on the availability of their amino 
acid precursor TYR, some studies have investigated the effects of an amino acid 
mixture lacking both TYR and it’s precursor phenylalanine (Harmer et al., 2001). 
Such a mixture decreases the availability of TYR to the brain and increases the 
competition for its transport across the BBB. Animal studies have shown that 
administration of a TYR-free mixture decreases brain TYR and catecholamine 
synthesis (McTavish et al., 1999), resulting in reduced locomotor responses 
(McTavish et al. unpublished data cited in Harmer et al. (2001)). Consistent with this, 
in humans TYR depletion was shown to affect DA function from a variety of different 
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measures (Harmer et al., 2001). The TYR-free mixture resulted in higher prolactin 
levels, which indicates reduced dopaminergic function within the brain. Moreover, 
TYR depletion impaired aspects of cognitive function and it was also reported that 
individuals felt ‘less good’ after the TYR-free compared to balanced mixture. 
Together, these findings suggest that TYR availability may negatively influence DA 
function in humans and thus supports the rationale for supplementing TYR to increase 
catecholamine synthesis and release.  
Since DA and NA have been associated with arousal, motivation, attention and motor 
control, several studies have utilised TYR as a nutritional supplement prior to extreme 
stress in an attempt to alleviate stress-related decrements in performance (physical 
and cognitive). It is suggested that similar to the effects of physical stress and heat-
stress, catecholamine concentrations also become depleted during exposure to other 
environmental stressors (cold and hypoxia) (O'Brien et al., 2007). The majority of 
literature assessing the effects of TYR is military based, with several investigations 
conducted by the US Army Research Institute (Banderet and Lieberman, 1989, 
Lieberman, 2003, Lieberman et al., 2005, Mahoney et al., 2007, O'Brien et al., 2007) 
and other army institutes (Deijen and Orlebeke, 1994, Deijen et al., 1999). The 
highlighted military investigations have primarily focused on aspects of cognitive 
function (complex; working memory, vigilance, tracking and simple; reaction time) 
and mood during exposure to acute stress, such as such as cold (Banderet and 
Lieberman, 1989, Mahoney et al., 2007, O'Brien et al., 2007) and hypoxia (Banderet 
and Lieberman, 1989), and paradigms involving both extended wakefulness (Neri et 
al., 1995) and the physical/emotional stress nexus (Deijen et al., 1999). Each of these 
aforementioned studies has demonstrated improvements in specific aspects of 
cognitive function after ingestion of TYR (100-300 mg.kg body mass-1); refer to 
Table 2.2 for an overview of these military based findings. Moreover, specific to hot 
environments, it has been shown that TYR improves the behavioural response (ability 
to cope) to exercise-heat-stress (41°C) and increases NA release, albeit in rodents and 
not humans (Lieberman et al., 2005).  
 
On the basis of these positive findings, several further studies have investigated the 
effects of TYR in relation to exercise performance in normal (Strüder et al., 1998, 
Chinevere et al., 2002, Sutton et al., 2005) and elevated/high ambient temperatures 
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(Tumilty et al., 2011, Watson et al., 2012, Tumilty et al., 2014, Coull et al., 2015) 
(see Table 2.2 for overview of these studies). All three of the studies conducted under 
temperate conditions failed to observe any beneficial effect of acute TYR ingestion on 
endurance performance (Strüder et al., 1998, Chinevere et al., 2002) or strength and 
power performance (Sutton et al., 2005). These findings are not surprising due to the 
questionable amount of stress experienced during exercise in normal ambient 
temperatures and the relationship between stress and catecholamine turnover as 
previously mentioned.  
 
Hence, all recent studies in this area have employed passive and active heat-stress 
based designs to examine the influence of TYR under extreme stress and attempt to 
elucidate its mechanistic properties. The first of these investigations reported a 
significant improvement in exercise capacity (15 ± 11%) after ingestion of 150 mg.kg 
body mass-1, compared to placebo when cycling to exhaustion in a hot environment 
(30°C; 50% RH) (Tumilty et al., 2011). To date, this is the first and only study to 
observe a positive effect of TYR on physical performance, despite the efforts of 
Watson et al. (2012) who attempted to replicate this study. Watson et al. (2012) 
reported that ingestion of TYR did not influence exercise capacity or any aspects of 
cognitive function (reaction time, information processing or memory) in the heat, 
despite a significant increase in plasma TYR concentration. Moreover, a follow up 
study by Tumilty et al. (2014) employed a pre-loaded time-trial design based on the 
theory that a benefit of TYR would be more apparent during self-paced exercise due 
to the greater influence of behavioural thermoregulation, motivation and arousal 
compared to constant load exercise (Nybo et al., 2014, Tumilty et al., 2014). 
However, this was not the case, as TYR ingestion (150 mg.kg body mass-1) did not 
influence time-trial performance when performed in a hot environment (30°C; 50% 
RH). Very recently, Coull et al. (2015) examined the effect of TYR ingestion (300 
mg.kg body mass-1) during exposure to a 90 min soccer-simulation protocol (iSPT; 
(Aldous et al., 2014)) in a warm environment (25°C; 40% RH). Interestingly, TYR 
had a positive effect on cognitive function (vigilance) and readiness to invest mental 
effort, but did not influence physical performance (distance covered during the soccer 
simulation).  
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Table 2.2. Overview of previous studies assessing the effects of TYR on cognitive function, exercise and a combination of both. 
Study 
  
TYR dose Exposure/exercise Blood samples  Cognitive function  Findings 
Cognitive function only     
Banderet and 
Lieberman 
(1989) 
 
2 x 50 mg/kg separated 
by 40 min (capsule)  
Cold and hypoxic 
(15 °C/ 4700 m) 
No 
  
Reaction time & vigilance 
performance + mood states 
  
↓ symptoms, adverse 
moods & performance 
impairments  
Shurtleff et al. 
(1994) 
150 mg/kg 2 h pre-
exposure 
Cold (4°C) Yes Working memory computer 
task 
↑ working memory 
↑ TYR, ↑ NE in cold 
Neri et al. 
(1995) 
150 mg/kg split dose 
 6 h into testing 
24 h sleep  
deprivation 
No Vigilance, psychomotor tasks 
and mood states 
↑ vigilance & psychomotor 
performance for 3 h 
Deijen et al. 
(1999) 
2 g/d over 5 days (protein 
rich drink) 
 
1 week physical 
combat course 
No Memory, tracking, dual-task 
and mood states 
↑ memory and tracking  
O'Brien et al. 
(2007) 
2 x 150 mg/kg separated 
by 4 h (energy bar) 
  
Cold air + water 
immersion (10°C) 
No Memory, pattern recognition, 
reaction time and vigilance 
 
↑ working memory & 
psychomotor tasks  
Mahoney et al. 
(2007) 
2 x 150 mg/kg separated 
by 4 h (energy bar) 
 
Cold water  
immersion (10°C) 
No Working memory, reaction 
time, vigilance and mood state 
↑ working memory & 
psychomotor tasks 
Kishore et al. 
(2013) 
 
6.5 g 90 min pre-
exposure (energy bar) 
90 min passive heat 
(45°C; 30% RH) 
Yes  Reaction time, ERP and CNV ↑ plasma DA, NA, A 
↑ cognitive function 
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Study 
 
TYR dose Protocol/exposure Blood samples  Cognitive function  Findings 
Exercise only      
Strüder et al. 
(1998) 
2 x 10 g (drink) Cycling to exhaustion Yes N/A ↑ plasma TYR 
↔ perf  
   
  
  
     
    
 
    
    
     
    
  
Chinevere et al.
(2002)
6 x 25 mg/kg (drink) 90 min cycling bout + 
time-trial 
Yes N/A ↑ plasma TYR
↔ TT perf
Sutton et al. 
(2005) 
150 mg/kg 30 min pre-
exercise (apple sauce) 
 
Load-carriage 
& phys perf battery 
 
Yes N/A ↑ plasma TYR and NA 
↔ endurance/strength/power  
  
Tumilty et al. 
(2011)  
150 mg/kg 1 h  
pre-exercise (drink) 
  
Cycling to exhaustion 
(30°C; 60% RH) 
Yes N/A ↑ plasma TYR 
↑ of 15 ± 11%  Tex  
 
Tumilty et al. 
(2014) 
 
 150 mg/kg 1 h  
 pre-exercise (drink) 
60 min cycling + time-trial 
(30°C; 60% RH) 
Yes N/A ↑ plasma TYR 
↔ TT perf  
Cognitive function & Exercise 
 
    
Watson et al. 
(2012)  
150 mg/kg total in 30 min 
intervals pre-exercise 
(drink) 
 
Cycling to exhaustion 
(30°C; 50% RH) 
Yes Stroop test, 
Sternberg memory 
& RVIP  
 
↑ serum TYR 
↔ Tex or cognitive function  
Coull et al. 
(2015) 
2 x 150 mg/kg separated 
by 4 h (drink) 
90 min soccer simulation  
(25°C; 40% RH) 
No Vigilance and  
dual-task (PsychE) 
↔ physical perf  
↑ vigilance and RTIME 
 
↑ = increase; ↓ = decrease; ↔ = no change; perf = performance; TT = time-trial; Tex = time to exhaustion. 
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From the available literature, it appears that TYR may not be useful in improving 
exercise performance in normal and hot conditions, however there is a large body of 
literature that support its use to improve aspects of cognitive function. A recent 
passive heat-stress investigation supports this statement after demonstrating that TYR 
alleviates heat-induced delays in reaction time during 90 min passive exposure to 
45°C; 30% RH (Kishore et al., 2013). This study also assessed higher levels of 
cognitive function using advanced brain imaging techniques (event related potentials; 
ERP), providing evidence that heat exposure causes an increase in P300 (reduced 
concentration) and M100 latency (reduced ability to react to a warning) and a 
decrease in M100 amplitude (linked with attention) which returned to near normal 
levels after ingestion of TYR. It was concluded that the higher DA and NA 
concentrations detected in the TYR trial might have maintained cognitive function by 
alleviating the decrements associated with heat-stress (Kishore et al., 2013). To date, 
this is the only TYR-heat-stress based study to assess DA and NA concentrations in 
combination with cognitive testing and brain imaging and thus provides valuable 
insight into the understanding of the mechanistic action of TYR in response to heat-
stress, which is an important advancement in this area.  
 
The contrasting findings in the literature in relation to TYR ingestion may be a result 
of the various methodological differences among previous studies. It has been 
suggested that the magnitude of activation of the catecholamine system, subsequent to 
the stress induced by the different exposures and exercise protocols, may be a possible 
explanation (Tumilty et al., 2014). As previously mentioned, highly stressful 
experiences increase catecholamine activity whereby there is a need for extra TYR 
supply, thus situations inducing more stress should hypothetically benefit from TYR 
ingestion (Lehnert et al., 1984, Foley and Fleshner, 2008). Furthermore, it has been 
highlighted that the diverse range of administration strategies (dose, form and source 
of the supplement) utilised by previous studies (see Table 2.2 for specifics) may also 
contribute to the differing findings (Tumilty et al., 2014, Coull et al., 2015). To assess 
the efficacy of TYR as an ergogenic aid, future studies must standardise these factors 
to enable appropriate conclusions to be made with minimal confounding variables. 
Investigation into the pharmacokinetics of TYR ingestion is also recommended before 
further experimental studies are conducted to identify an ‘optimal’ dose (Coull et al., 
2015). 
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Data regarding the pharmacokinetics, or dose response relationships of TYR ingestion 
are currently limited. Lack of information in this area makes it difficult to identify the 
optimal dose and time to ingest TYR prior to exercise or stressful exposure. Not all 
studies assessing the effects of TYR on performance aspects have reported 
plasma/serum measures of TYR and amino acid concentrations (see Table 2.2). To 
date, only one previous study has directly investigated the pharmacokinetics of two 
separate doses of TYR (100 and 150 mg.kg body mass-1) and reported dose related 
increases in plasma TYR whereby the 150 mg.kg body mass-1 dose provided the 
highest elevation (Glaeser et al., 1979). Furthermore, it was observed that TYR 
concentration in the blood peaked 2 h post ingestion of the supplement. However, this 
study provides very basic details and only assessed small doses of TYR, thus further, 
updated research is required due to the popularity of TYR in research and in the field. 
The most commonly administered acute doses within the literature are 150 (Neri et 
al., 1995, Sutton et al., 2005, Tumilty et al., 2011, Watson et al., 2012, Tumilty et al., 
2014) and 300 mg.kg body mass-1 TYR (ingested in a double dose of 150 mg.kg body 
mass-1 TYR 4 h apart) (Mahoney et al., 2007, O'Brien et al., 2007, Coull et al., 2015), 
hence it would be appropriate to investigate the direct effects of these doses on TYR 
concentrations in the blood. 
 
2.7 Overall Summary 
It is evident that exercise in hot environments accelerates the development of fatigue, 
due to a number of contributing factors, consequently deterring performance in 
physical and cognitive tasks (Nybo et al., 2014). Specifically, one contributing factor 
is the influence of neurotransmitters on the fatigue process. It has been highlighted in 
animal models that exposure to stress leads to an increase (Meeusen et al., 1997) and 
subsequent depletion in NA and DA levels with performance decreasing accordingly 
(Lehnert et al., 1984). Ingestion of TYR, a catecholamine precursor, has shown some 
evidence of beneficial effects on cognitive function during stress (Banderet and 
Lieberman, 1989, Mahoney et al., 2007, O'Brien et al., 2007, Kishore et al., 2013, 
Coull et al., 2015) but evidence of a positive influence on physical performance in 
limited to one study (Tumilty et al., 2011). Methodological inconsistencies in the 
literature may be a possible explanation for some of the opposing findings due to a 
diverse range of protocols, stressful exposures, and TYR administration strategies.  
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Before any further experimental studies are conducted, investigation into the required 
dose of TYR to elicit significant elevations in blood TYR concentrations is necessary 
(Coull et al., 2015). Furthermore, as numerous military operations are conducted 
overseas in hot environmental conditions, investigation into the effect of TYR under 
similar conditions may be useful due to the popularity and success of TYR in previous 
military based studies. Optimal performance in such conditions is paramount as heat-
induced errors in judgement and decision making may have severe consequences on 
the health and safety of individuals, particular military personnel (Gaoua et al., 2011). 
Thus any small dietary mediated improvements in performance may be of great 
benefit to military personnel.  
 
 
2.8 Aims and Hypotheses 
Experimental Chapter 1 
To investigate the effects of acute TYR ingestion strategies (0, 150 and 300 mg.kg 
body mass-1 TYR administered in 2 equal doses, 4 h apart) on serum TYR 
concentrations at rest. - Ingestion of 150 and 300 mg.kg body mass-1 TYR will significantly increase 
serum concentrations of TYR compared to control.  - Ingestion of 300 mg.kg body mass-1 TYR will induce significantly higher peak 
concentrations of TYR compared to 150 mg.kg body mass-1.   
 
Experimental Chapter 2 
To investigate the effects of the ‘optimal’ TYR dose (ascertained from experimental 
chapter 1) on steady state exercise, cognitive function and time-trial performance 
during a military based exercise protocol in the heat (40°C; 30% RH). 
 - Ingestion of 150 mg.kg body mass-1 TYR will significantly improve aspects of 
cognitive function. - Ingestion of 150 mg.kg body mass-1 TYR will not influence time-trial 
performance.
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CHAPTER 3: General Methodology  
This chapter outlines the general procedures employed within the studies described in 
experimental chapters 1 and 2. Schematics are provided within each experimental 
chapter for an overview of each study design and experimental protocol. 
3.1 Participants 
Upon ethical approval from the Institute for Sport and Physical Activity Research 
(ISPAR) Ethics Committee (approval no. 2013SPA006) healthy, recreationally active 
(5-10 h.wk-1 physical activity) males were recruited via convenience sampling. Prior 
to participation, a detailed information sheet (Appendix A) outlining the purpose, 
procedures and potential risks of the study was provided to each participant and also 
verbally explained by the researcher. Participants were able to ask any questions 
regarding their involvement in the study and were fully aware that they could 
withdraw at any time, without disadvantage or explanation. Subsequently, written 
informed consent was obtained in line with the principles stated in the Declaration of 
Helsinki (Appendix B). To minimise potential risks to themselves and the researcher, 
participants were also medically screened via a blood analysis (Appendix C), PAR-Q, 
and risk assessment questionnaire (Appendix D). All participants were non-smokers, 
free from any known medical condition, and musculoskeletal injury. Participants were 
excluded from the study if it was deemed unsafe for them to participate (Appendix A 
and C for risks associated with participating).  
 
Written pre-test instructions (Appendix E) were provided, and participants were 
verbally briefed on these prior to testing. Participants were required to refrain from 
alcohol, caffeine, strenuous exercise and exposure to extreme environments (i.e. heat 
or hypoxic) for 24 h prior to each laboratory visit (Tumilty et al., 2011, Watson et al., 
2012, Coull et al., 2015). Additionally participants abstained from ingestion of any 
supplements (including protein, BCAA and caffeine) and did not take part in any 
other research projects involving supplementation of any kind for at least four weeks 
prior to testing. Participants were not heat acclimated or acclimatised prior to taking 
part in the experiments and study 2 (heat-based) took place in UK autumn and winter 
months. Each participant completed 24 h food diaries throughout the study to enable 
them to replicate their diet on subsequent visits (Tumilty et al., 2011, Watson et al., 
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2012, Coull et al., 2015). Furthermore, participants were instructed to drink 500 mL 
of water prior to arriving at the laboratory in line with the American College of Sports 
Medicine Position Stand (Sawka et al., 2007). Upon arrival, participants ingested a 
further 250 mL of water, before providing a urine sample for assessment of hydration 
status via a urine refractometer (Pocket Pal-Osmo, Atago Vitech Scientific, HAB 
Direct, UK). Samples were assessed in duplicate and participants were deemed 
euhydrated if urine osmolality was <600 mOsm·Kg-1 H2O (Hillman et al., 2011, 
Hillman et al., 2013). All pre-experimental controls were monitored via a pre-test 
questionnaire (Appendix F), with apparent adherence confirmed at 100% in all 
instances. Data and information collected about the participants was stored on a 
password-protected laptop, which only the primary researcher had access to. No 
reference was made to individual participants to ensure anonymity and confidentiality 
was preserved. 
 
3.2 Anthropometric Data 
Anthropometric data was collected during the initial visit upon arrival at the 
laboratory. Body mass (kg) and height (cm) were recorded using Digital Tanita 
weighing scales, accurate to the nearest g (BWB0800, Allied Weighing, UK) and a 
Stadiometer, accurate to the nearest mm (Holtain Ltd, UK), respectively. Body fat 
percentage (%) was also assessed via Air Displacement Plethysmography (BodPod 
2000A, Cranlea, UK) on a subsequent day in line with manufactures instructions, in a 
fasted state (no food/fluid for 4 h) with an evacuated bladder.  
 
3.3 Tyrosine supplementation 
The TYR supplement (L-Tyrosine) was sourced from an Advanced Medical Nutrition 
company (Nutricia Ltd, UK) in line with Watson et al. (2012). The purity of this 
supplement was assessed via high-performance liquid chromatography (HPLC) and 
confirmed to contain a satisfactorily high concentration of TYR (>98%). For the 
purpose of this research the supplement was added to a drink (a liquid suspension was 
formed) [250 mL sugar free lemon squash (Tesco, UK) and water] and orally ingested 
by participants in a double-blind manner, in line with previous research (Tumilty et 
al., 2011, Watson et al., 2012, Tumilty et al., 2014, Coull et al., 2015). To ensure the 
TYR ingestion was double-blinded, all drinks were provided in opaque sports bottles 
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and shaken vigorously immediately before ingestion to disguise the substance and 
were indistinguishable in taste and texture to the participants. Each drink was 
measured using the same weighing scales, accurate to the nearest 0.01 mg (Mettler, 
AT250). The specific dose of TYR administered is stated in each respective 
experimental chapter.  
 
3.4 Statistical Analyses 
Power calculations (G*Power 3) were conducted for both studies to identify the 
number of participants required to obtain a statistical power of 99%, at an alpha level 
of 0.05. All data was analysed using the statistical software package IBM SPSS 
statistics for Macintosh, Version 20 (IBM Corp, Armonk, NY). Statistical 
assumptions were assessed using conventional graphical methods (Grafen et al., 
2002) and deemed plausible for each variable. Quantile-quantile (Q-Q) plots were 
used to assess the normality of distribution of all data collected and was deemed 
plausible for each variable. Linear mixed models were used to identify differences in 
the dependant variables between groups (group x time) and conditions (condition x 
time) in experimental chapter 1 and 2, respectively (see section 4.3.7 and 5.3.6 for 
details). Where significance was obtained, Sidak post-hoc tests were used to locate 
significant pairs. Linear mixed models where chosen as this type of analysis permits 
missing data and can identify the most appropriate covariate structure for repeated 
measures data. Although there were very few missing data (only in study 1 with 3 
missing blood samples), this analysis was preferred. The most suitable covariate 
model was decided using the likelihood variable test, which uses the χ2 critical test 
statistic to select the best fitting model, based on the change in the -2 restricted log 
likelihood of the two models. Furthermore, normality and homogeneity of variance of 
the residuals were assessed using Q-Q plots and scatter plots respectively, and were 
deemed plausible in each instance. Two-tailed statistical significance was accepted at 
the p < 0.05 level.  
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CHAPTER 4: Experimental Chapter 1 – Serum Response of Acute 
Tyrosine Ingestion at Rest 
 
4.1 Introduction 
Prolonged exposure to hot environments can accelerate the onset of fatigue, 
compromising performance in both physical (González-Alonso et al., 1999, Nybo et 
al., 2014) and cognitive tasks (Maughan et al., 2007, Simmons et al., 2008, Gaoua et 
al., 2011). Many interventions to alleviate fatigue and performance decline in stressful 
environments have been investigated, including various nutritional manipulation 
strategies (Roelands and Meeusen, 2010, Meeusen, 2014). The amino-acid TYR, first 
investigated in a performance setting by the US Army Research Institute (Banderet 
and Lieberman, 1989, Lieberman et al., 2005, Mahoney et al., 2007, O'Brien et al., 
2007), has seen several studies examining its effects on exercise performance 
(Tumilty et al., 2011, Watson et al., 2012, Tumilty et al., 2014, Coull et al., 2015) and 
cognitive function (Watson et al., 2012, Coull et al., 2015, Tumilty et al., 2014).  
Despite the previous positive military based findings (Banderet and Lieberman, 1989, 
Deijen et al., 1999, Mahoney et al., 2007, O'Brien et al., 2007), there are currently 
mixed opinions on the efficacy of TYR as an ergogenic aid, due to recent opposing 
findings (Watson et al., 2012, Tumilty et al., 2014). This inconsistency may be a 
result of the varying administration strategies and the TYR supplement itself 
(composition, purity, etc.). The most commonly administered dose within the 
literature is between 150 and 300 mg.kg body mass-1 TYR, typically ingested 1 h pre-
exercise (Tumilty et al., 2011, Tumilty et al., 2014) or in two separate doses with a 4 
h loading phase (Mahoney et al., 2007, O'Brien et al., 2007, Coull et al., 2015). Lack 
of data on the blood response to TYR ingestion restricts its use as a nutritional aid due 
to limited knowledge on dose response relationships (Marriott and Thomas, 1994). 
Thus, data on dosing strategies (relative to peak plasma/serum TYR) would provide a 
standardised prescription for future research to utilise when investigating the effects 
of TYR (Tumilty et al., 2014, Coull et al., 2015). To the authors knowledge only one 
study has directly investigated this using 100 and 150 mg.kg body mass-1 at rest, 
providing very basic information on small doses of TYR (Glaeser et al., 1979).  
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4.2 Aim and Hypotheses 
The purpose of this study was to investigate the effects of acute TYR ingestion 
strategies (0, 150 and 300 mg.kg body mass-1 TYR administered in 2 equally split 
doses, 4 h apart) on serum TYR concentrations at rest. It was hypothesised that the 
150 and 300 mg.kg body mass-1 TYR doses would significantly increase serum 
concentrations of TYR compared to control. Secondly, it was hypothesised that 
ingestion of 300 mg.kg body mass-1 TYR would induce significantly higher peak 
concentrations of TYR compared to 150 mg.kg body mass-1.   
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4.3 Methodology  
4.3.1 Participants 
Twenty-one healthy, healthy males volunteered to participate in this study (median: 
age 21 y, range: 19-26 y, mean ± SD: height 178.4 ± 7 cm, body mass 76.3 ± 10.3 kg, 
body fat 14.3 ± 3.6%, activity level 6.7 ± 2 h.wk-1) (see table 4.1 for group 
descriptives). Inclusion and exclusion criteria is detailed in section 3.1. 
 
 
 
 
4.3.2 Experimental Design 
This study employed a double-blind, randomised, independent group design (see 
Figure 4.1 for study schematic) whereby each participant was randomly assigned (by 
a separate laboratory technician whom was not involved in the study) to one of three 
groups (n = 7 per group); control (CON; placebo - no TYR), low dose (LOW; 150 
mg.kg body mass-1 TYR) or high dose (HIGH; 300 mg.kg body mass-1 TYR). 
Participants remaining within the laboratory for a period of 9 h (0800 until 1700). 
During this time, blood was drawn every hour, as described in further detail below in 
section 4.3.4. TYR was ingested in two separate doses, separated by a 4 h loading 
phase, at both 0900 and 1300 (see section 4.3.6 for further details). Standardised 
breakfast and lunch were provided at 0800 and 1200 respectively. 
Measure CON (n = 7) LOW (n = 7) HIGH (n = 7) 
Age (y) 21 ± 1 22 ± 2 21 ± 2 
Height (cm) 181.4 ± 7.5 176.2 ± 7.7 177.7 ± 5.8 
Mass (kg) 79.9 ± 10.8 73.2 ± 11.9 75.7 ± 8.2 
Body fat (%) 15.1 ± 3.2 13.9 ± 4 13.9 ± 4 
Table 4.1. Participant anthropometric data in each group. Data is mean ± SD.  
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Figure 4.1. Schematic outlining the design and order of testing in study 1. 
  
4.3.3 Standardised meals 
Breakfast and 250 mL water was provided on arrival at the laboratory (0800) after an 
overnight fast. Standardised breakfast and lunch consisted of cornflakes (Kellogg’s, 
UK) and semi-skimmed milk (Asda, Bedford, UK), which was weighed out (to 
nearest g and mL respectively) by the researcher for each participant, according to 
their resting energy expenditure. This was calculated using the following predictive 
metabolic equation by Mifflin et al. (1990): 
10 x body mass (kg) + 6.25 x height (cm) – 5 x age (yrs) – 161 
Study 1  
 Double-blind, randomised, independent group design 
Group 1 (CON) 
Control 
No TYR 
Group 2 (LOW) 
150 mg/kg 
TYR 
Baseline measures and 
blood sample 
Ingest first dose of TYR (75 
mg/kg or 150 mg/kg) or 
CON drink (0900) 
Ingest second dose of TYR 
(75 mg/kg or 150 mg/kg) or 
CON drink (1300) 
4 h rest 
Blood sample taken at 1, 2, 
3 and 4 h post ingestion 
Group 3 (HIGH) 
300 mg/kg  
TYR 
Blood sample taken at 1, 
2, 3 and 4 h post ingestion 
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The exact amount of cornflakes and milk equated to 20% of each participants total 
resting energy expenditure, which was consumed at both breakfast and lunch. 
Participants were instructed to consume this meal within 10 min to ensure 
standardisation between participants. 
 
4.3.4 Blood collection 
Frequent blood samples were required for this study, and therefore cannulation was 
the preferred method of blood sampling. A cannula (22G/1” Vasofix Safety, B Braun, 
UK) was inserted into an antecubital vein of the preferred arm and secured in place 
with a sterile dressing (Niko-Guard IV Dressing, DM Wood Medical, UK) to remain 
in place for a 9 h period (see Figure 4.2 for illustration). Blood samples were drawn 
from the inserted cannula at 9 time points (baseline, 1, 2, 3, 4, 5, 6, 7 and 8 h), directly 
into three separate Vacuette® containers (Vacuette® Grenier Bio-One, UK) treated 
with K3 Ethylenediaminetetraacetic acid (EDTA) (1 x 5 mL tube) and Serum Clot 
Activator (2 x 6 mL tubes) in line with the Vacuette® recommendations (2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Illustration of blood drawn from inserted cannula. 
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4.3.4.1 K3EDTA Treated Blood (Plasma Volume) 
Upon collection, EDTA treated blood was immediately pipetted from the K3EDTA 
Vacuette® containers into heparinized capillary tubes (Hawksley & Sons Ltd, UK), 
centrifuged at 5000 rpm for 3 min (Hawksley Mircro Haematocrit centrifuge) and 
then measured from a Haematocrit reader (Hawksley, UK). Further blood from the 
same tube was pipetted into microcurvettes and analysed for haemoglobin 
concentration via a B-Haemoglobin photometer (Hb 201+, Hemocue Ltd, UK). 
Haematocrit and haemoglobin concentrations were measured in duplicate for each 
time point and the average of the two readings was recorded. Changes in plasma 
volume (PV) were then estimated from the values of haematocrit (Hct) and 
haemoglobin (Hb) using the following Dill and Costill (1974) method:  
 
% ΔPV = [(Hbpre/Hbpost) x [(100 - Hctpost)/(100 – Hctpre)] – 1] x 100 
ΔPV = [(100 – Hbb/Hba) – x 1- (Hcta – 100)/(1 – Hctb -100)] - 100 
 
Where ΔPV is percentage change of PV, subscript b is baseline and subscript a is 
post. Blood results were subsequently adjusted as a result of changes in plasma 
volume. 
 
4.3.4.2 Serum Clot Activator Treated Blood 
The blood drawn into the Serum Clot Activator containers was left to clot at room 
temperature for 1 h before being centrifuged (ThermoScientific Multifuge, X3R) at 
1500 g for 10 min at 4°C to yield serum in line with Watson et al. (2012) and the 
Vacuette® Handling Recommendations. The serum was then immediately removed 
from the clot, pipetted into a separate sterile container (CryoTube, Fisher Scientific, 
UK) and stored in duplicate at -80°C prior to analysis.  
 
4.3.5 Amino Acid Analysis 
Serum stored at -80°C for amino acid analysis was deproteinized using 12-M 
perchloric acid (70% PCA) (Sigma-Aldrich, UK) containing an internal standard (40 
mM norvaline). Deproteinization was achieved by adding 12.5 μl of perchloric acid to 
an eppendorf tube with 500 μl serum. This was then thoroughly vortexed (Vortex 
Mixer, Phillip Harris) for 20 s before leaving on ice to cool for 15 min. Each tube was 
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centrifuged at high speed (10000-14000 rpm) and the resulting supernatant was stored 
on ice and neutralized with an equal volume of freon-trioctylamine (78% v/v 1,1,2-tri- 
chlorotrifluoroethane, 22% v/v trioctylamine). Amino acid concentrations of the 
filtered extract were determined by reverse-phase HPLC with ultraviolet detection 
using a Zorbax eclipse Amino Acid Analysis (AAA) column (4.6 × 75 mm, 3.5 μm) 
(Agilent Technologies UK Ltd, Cheshire, UK) with precolumn derivatization using 
orthophthalaldehyde (Henderson, Ricker, Bidlingmeyer, & Woodward, 2000). This 
method is in line with the amino acid analysis carried out by Watson et al. (2012). 
 
Note: Amino acid analysis is for serum TYR concentration only. It was the authors 
aim to include LNAA data as well as the serum TYR data to highlight the ratio of 
TYR:LNAA in line with other previous research, however this data is unavailable to 
include in the thesis. This has been acknowledged as a limitation within the discussion 
of this chapter. 
 
 
4.3.6 Experimental Procedure 
Participants abstained from food or drink (other than water) after 2100 on the day 
prior to testing and until they arrived at the laboratory the next morning at 0800. 
Unless indicated otherwise, participants spent their time at rest within a temperature 
and humidity controlled laboratory and consumed meals in the adjoined food 
preparation room (both rooms were controlled at 19-21°C; 40-50% RH). Upon arrival 
at the laboratory, participants were immediately provided with breakfast, conforming 
to the standardised meal detailed in section 4.3.3. No additional food was consumed 
during the day other than the meals provided, however water was consumed ad 
libitum. Approximately 30 min post breakfast (~0830), a urine sample was provided 
by the participant and analysed to assess hydration status as described in section 3.1. 
Participants then completed a visual analogue scale (VAS) for gastric discomfort. 
Immediately after the first blood sample (0900) after being seated for 30 min, 
participants consumed either the CON, LOW or HIGH TYR dose (see Figure 4.1 for 
schematic). The standardised meal was provided again for lunch (1200) and following 
this, the CON, LOW or HIGH TYR dose was again ingested. Total TYR ingested 
after both doses was 150 mg.kg body mass-1 in LOW and 300 mg.kg body mass-1 in 
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HIGH. This TYR dosing strategy (two separate doses of TYR, ingested 4 h apart) is 
in line with previous military (Mahoney et al., 2007, O'Brien et al., 2007) and sport 
specific (Coull et al., 2015) based research. After the last blood draw at 1700, the 
cannula was removed and the participant was then free to leaving the laboratory. 
 
4.3.7 Statistical analyses 
An a priori power calculation (G*Power 3) was used to determine the number of 
participants required for this study (n = 7 in each group) with an alpha level of 0.05 
and statistical power of 99%, using TYR concentrations reported in previous work 
(Watson et al., 2012) and based on estimation (means = 50, 100 and 150, SD = 41) 
(Appendix G). Main statistical analyses were completed using linear mixed models 
(IBM SPSS statistics for Macintosh, Version 20, Armonk, NY) to assess mean 
differences in baseline anthropometric data, serum TYR concentrations, RTIPE and 
RTIME, gastric discomfort and blood pressure over time and between groups (CON, 
LOW and HIGH). Where significance was obtained, Sidak post-hoc tests were used to 
locate significant pairs. Ninety-five percent confidence intervals (95% CI) were also 
presented where necessary. Two-tailed statistical significance was accepted at the p < 
0.05 level.  
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4.4 Results 
4.4.1 Anthropometric data 
No significant differences were observed in participants’ baseline anthropometric data 
between the CON, LOW or HIGH group, including age (F2,18 = 2.10, p = 0.15), height 
(F2,18 = 1.03, p = 0.38), body mass (F2,18 = 0.75, p = 0.49) and body fat percentage 
(F2,18 = 0.23, p = 0.80) (see section 4.3.1 for descriptive Table 4.1). 
 
4.4.2 Serum Tyrosine concentrations 
Baseline serum TYR concentrations were not significantly different (p > 0.05) 
between the CON (64.3 ± 10.6 μmol/L), LOW (61.5 ± 17.8 μmol/L) and HIGH (65.9 
± 12.6 μmol/L) group. Over the 9 h period, a significant main effect of group was 
observed in mean TYR concentration (F2,18 = 86.71, p < 0.001) between CON (60 ± 
11.1 μmol/L), LOW (214.7 ± 72.9 μmol/L) and HIGH (309.8 ± 120.5 μmol/L). On 
average, TYR concentration in the HIGH group was 44% and 415% higher than the 
LOW (p < 0.001, 95% CI = 44.6-145.7 μmol/L) and CON (p < 0.001, 95% CI = 
199.3-300.4 μmol/L) group, respectively (Figure 4.3). A significant effect of time 
(F8,144 = 46.97, p < 0.001) and group x time interaction effect (F16,144 = 14.74, p < 
0.001) was also observed. The peak in serum TYR occurred 2 h post the second dose 
in both the HIGH and LOW group with the HIGH dose producing the largest peak 
(399.5 ± 69 μmol/L) compared to the LOW dose (278.5 ± 76.4 μmol/L) (p < 0.001, 
95% CI = 55.5-186.5 μmol/L). Despite this, the second dose of TYR did not 
significantly elevate serum TYR concentrations from the first dose, in either the 
HIGH (350 vs 399 μmol/L respectively: p = 0.38, 95% CI = -113.75-14.6 μmol/L) or 
LOW (221 vs 279 μmol/L respectively: p = 0.13, 95% CI = -122.2-6.2 μmol/L).  
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4.4.4 Gastric discomfort 
There was a significant effect of time for mean gastric discomfort (F8,144 = 4.57, p < 
0.001) with highest ratings occurring at baseline which was after breakfast and before 
any supplement was consumed (21 ± 21 mm in CON, 39 ± 74 mm in LOW and 23 ± 
45 mm in HIGH). No other significant differences were observed over time (p > 0.05) 
throughout the remainder of the testing day. Furthermore, no significant main effect 
of group was observed (F2,18 = 0.36, p = 0.7) between CON (5 ± 11 mm), LOW (11 ± 
30 mm) and HIGH (3 ± 16 mm) and there was no significant group x time interaction 
effect (F16,144 = 4.80, p = 0.95) for mean gastric discomfort. 
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Figure 4.3. Mean serum TYR concentrations in each group (CON, LOW 
and HIGH), across all time points. Values are mean ± SD. *Denotes 
significant differences between conditions, #significant differences over 
time, ✝significant group x time interaction (p < 0.05).  
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4.5 Discussion 
The aim of this experimental chapter was to investigate the acute effects of different 
TYR doses (CON, LOW and HIGH) on serum TYR concentrations at rest. As 
expected, the main finding was that the HIGH dose (2 doses of 150 mg.kg body mass-
1 TYR) elevated serum TYR concentrations significantly more than the LOW dose (2 
doses of 75 mg.kg body mass-1 TYR) and CON (no TYR). Furthermore, it was 
observed that ingestion of a second, identical dose of TYR, 4 h post the first dose, did 
not significantly increase the peak in serum TYR in either the LOW or HIGH group. 
These findings suggest that ingestion of a single dose of 150 mg.kg body mass-1 TYR 
is sufficient to significantly elevate serum TYR concentrations (fivefold increase from 
baseline) and that a second dose, as administered in previous studies (Mahoney et al., 
2007, O'Brien et al., 2007, Lieberman et al., 2014, Coull et al., 2015), may not 
provide any additional worth while increase.  
 
To the author’s knowledge, only one previous study has directly investigated the 
effects of acute oral TYR ingestion on amino acid concentrations at rest, in humans 
(Glaeser et al., 1979). Although assessing smaller, single doses of TYR (100 and 150 
mg.kg body mass-1) the findings of Glaeser et al. (1979) support the present results, 
demonstrating dose-related increases with significantly higher elevations observed 
after ingestion of larger doses of TYR. Furthermore, peak elevations in blood TYR 
occurred 2 h post-ingestion for all dosages in the current study and in the investigation 
by Glaeser et al. (1979). Additionally, in the present study this 2 h post-ingestion peak 
also occurred after ingestion of the second dose of TYR.  
 
The findings of this experimental chapter may be of use to researchers conducting 
future investigations involving TYR and also to athletes, military personnel and other 
individuals interested in the use of TYR for performance purposes. From the available 
data, individuals can identify the optimal time to consume TYR, depending on the 
nature of their sport or occupation, to ensure a sufficient elevation in blood TYR 
concentration occurs. The present study revealed that ingestion of a double dose of 
150 mg.kg body mass-1 TYR did not significantly increase serum concentrations of 
TYR compared to a single dose. This may be beneficial in situations with limited time 
before exposure to a stressful stimulus, in which individuals may consume a single 
dose of 150 mg.kg body mass-1 TYR 1-2 h prior and still benefit from similar rises in 
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circulating TYR, instead of a prolonged double dose administration strategy. For 
example, prior to military operations in extreme conditions, a quick and simple 
administration strategy may be more appropriate and appealing to personnel. 
Moreover, as no side effects were observed in the present study and previous others, it 
can be suggested that TYR is a safe nutritional supplement when ingested acutely 
(Glaeser et al., 1979, Sole et al., 1985, Banderet and Lieberman, 1989, Mahoney et 
al., 2007, O'Brien et al., 2007, Tumilty et al., 2011, Coull et al., 2015). 
 
Although the findings of this study may be a useful guide, it is not certain that a 
significant rise in blood TYR concentration will translate to significant improvements 
in performance. However, it is known that increasing the availability of TYR through 
oral supplementation increases its ratio to other LNAA, which is the primary 
determinant of TYR uptake across the BBB and DA synthesis (Fernstrom and Faller, 
1978). Furthermore, there is evidence to show that acute depletion of plasma TYR 
(via a TYR and phenylalanine free mixture), reduces the ratio of TYR:LNAA and 
consequently decreases exercise capacity in the heat (Tumilty et al., 2014), 
highlighting the importance of TYR availability during acute stress. Therefore, it may 
be speculated that a fivefold increase in serum TYR observed in the present study 
after ingestion of 150 mg.kg body mass-1 TYR, might provide ergogenic benefits 
during extreme stress.  
 
The methodology of experimental chapter 1 contains several limitations, which 
should be considered in future research. The use of only two different doses of TYR 
(150 and 300 mg.kg body mass-1) limits the scope of the investigation. Assessment of 
a variety of doses and administration strategies may have provided better dose 
response relationship data, however as the majority of previous research utilises either 
150 or 300 mg.kg body mass-1 TYR, it seemed appropriate to assess these two 
commonly utilised doses, which have had experimental effects within humans 
previously (Mahoney et al., 2007, O'Brien et al., 2007, Tumilty et al., 2011, Coull et 
al., 2015). It would have been ideal to assess the effects of 150 and 300 mg.kg body 
mass-1 TYR in single doses, but due to ethical considerations, it was not possible to 
assess such large doses of TYR without administering in two separate doses. Another 
limitation of the present chapter is the absence of LNAA data, which means that TYR 
cannot be expressed as a ratio with other competing amino acids. As this ratio is a 
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major factor in the transportation of TYR across the BBB not including this data 
limits the conclusions that can be made regarding the effects of elevating serum TYR. 
Furthermore, the lack of performance measures within this investigation may be 
considered a limitation. Inclusion of cognitive testing throughout the 9 h testing 
period may have provided useful information, however as TYR is suggested to exert 
its beneficial effects during acute stress, it is likely that there would have been no 
change in cognitive function between groups under the present conditions. Therefore, 
the sole purpose of experimental chapter 1 was to inform and identify a suitable dose 
to be assessed in experimental chapter 2 and in future research. 
 
4.6 Conclusion  
In conclusion, this study demonstrates that ingestion of a single dose of 150 mg.kg 
body mass-1 TYR may be sufficient to elevate serum TYR concentrations (350 
μmol/L) without the need for a second dose. Future research should investigate the 
effects of 150 mg.kg body mass-1 TYR on performance and mood in variety of 
stressful environments.  
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CHAPTER 5: Experimental Chapter 2 - Effect of Tyrosine Ingestion 
on Cognitive Function and Load-carriage Performance in the Heat 
  
5.1 Introduction 
Military based operations and occupational pursuits are often performed in extreme 
environments, commonly in hot and/or humid conditions (Marriott, 1993, Hocking et 
al., 2001). Deployment overseas in countries with semi-arid environments (such as 
Iraq or Afghanistan) may result in prolonged exposure to high ambient temperatures 
≥40°C. During such extreme heat exposure, military personnel may be required to 
carry out demanding physical and cognitive tasks whereby the outcome could be life 
threatening, thus optimal performance is paramount (Orasanu and Backer, 1996). It is 
well established that prolonged exercise-heat-stress impairs both exercise 
performance and cognitive function, attributed to both peripheral and central factors, 
whereby fatigue occurs prematurely (Cheung and Sleivert, 2004, Nybo et al., 2014). 
Furthermore, this thermal strain may be exacerbated when wearing protective clothing 
and carrying heavy loads (Havenith, 1999, Cheung et al., 2000, Dewhurst et al., 
2014), therefore the military are frequently investigating ways to alleviate such 
impairments for safety, protection and performance purposes (Nindl et al., 2002). 
 
Nutritional manipulation strategies are commonly used to dampen the adverse affects 
associated with heat-stress, through various centrally mediated pathways (Lieberman, 
2003, Roelands and Meeusen, 2010, Meeusen, 2014). The amino acid TYR exerts its 
effects by increasing catecholamine synthesis, which is suggested to improve 
motivation, arousal and motor control during stress (when catecholamine 
concentration begins to deplete) (McMorris et al., 2006, Watson, 2008, Kishore et al., 
2013). As previously discussed, the use of TYR is relatively popular in the US 
military however, recent evidence from controlled laboratory settings, question its 
efficacy (Watson et al., 2012, Tumilty et al., 2014), and thus further research is 
required to elucidate this.  
 
In experimental chapter 1, the pharmacokinetics of two separate doses of TYR were 
examined and it was established that a single dose of 150 mg.kg body mass-1 TYR was 
sufficient to elevate serum TYR levels at rest, without inducing any side effects. It is 
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yet to be investigated whether this dose of TYR may influence exercise performance 
or cognitive function in a laboratory controlled, simulated military setting, in a hot 
environment. Moreover, the only previous studies assessing the effects of TYR in 
extreme heat (>30°C) were either conducted on rodents (Lieberman et al., 2005) or 
using passive heat protocols (Kishore et al., 2013), thus there is a need to investigate 
this area further. 
 
5.2 Aim and Hypotheses 
The purpose of this study was to utilise the identified dose of TYR (150 mg.kg body 
mass-1) from the findings of experimental chapter 1 and investigate its effects on 
physical and cognitive performance utilising a military based protocol (25 kg load-
carriage) in the heat (40°C; 30% RH). It was primarily hypothesised that ingestion of 
150 mg.kg body mass-1 TYR would significantly improve aspects of cognitive 
function compared to placebo. Secondly, it was hypothesised that TYR would not 
influence 2.4 km time-trial performance. 
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5.3 Methodology 
5.3.1 Participants 
Eight healthy, recreationally active, male volunteers participated in this study (mean ± 
SD: age 23 ± 1 y, height 176.4 ± 5.9 cm, body mass 79 ± 11.5 kg, body fat percentage 
13.1 ± 2.8%, ?̇?𝑉O2max 53.4 ± 5.7 ml.kg.min-1 and activity level 7.1 ± 1.8 h.wk-1). 
According to recent guidelines to classify subject groups (albeit cycling based), the 
participants in the present study fall under performance level 2, which indicates that 
they are recreationally trained (De Pauw et al., 2013). Inclusion and exclusion criteria 
is detailed in section 3.1 
 
 
5.3.2 Experimental Design 
This study employed a double-blind, counter-balanced, crossover design in which 
participants visited the laboratory on four separate occasions; two familiarisation 
sessions and two experimental conditions. During the experimental conditions, 
participants either ingested TYR and or a placebo (see Figure 5.1 for study overview 
schematic). All visits to the laboratory were separated by at least 7 d to allow for a full 
recovery and all main experimental trials were performed at the same time of day (± 
30 min) to minimise the influence of circadian variation (Drust et al., 2005). 
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Familiarisation 1 
18oC 
Familiarisation 2 
18oC 
VO2max 
test 
Condition 1 
40oC/ 30 % RH 
Condition 2 
40oC/ 30 % RH 
At least 7 days rest 
Shortened load 
carriage protocol 
Full load 
carriage protocol 
Full load carriage 
protocol  
TYR/PLA  
1 h pre-exercise  TYR/PLA  1 h pre-exercise  
Full load carriage 
protocol 
Cognitive 
test battery 
TYR (150 mg/kg) 
or PLA ingestion 
1 h pre-exercise 
60 min treadmill walk at 6.5 km/h 
with 25 kg backpack 
2.4 km self-
paced time-trial 
Cognitive 
test battery 
Cognitive 
test battery 
Cognitive 
test battery 
Cognitive test 
battery at 30 min 
5 min measures 
HR 
RPE, TSS 
RTIPE/RTIME 
Tre and Tsk 
0.5 km measures 
HR 
RPE, TSS 
RTIPE/RTIME 
Tre and Tsk 
15 min seated recovery 
Figure 5.1. Schematics detailing an overview and the experimental procedures of study 2 (double-blind, counterbalanced, crossover design) 
All main experimental trials were performed in 40oC; 30 % RH. 
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5.3.3 Familiarisation 
All participants were required to attend two familiarisation sessions prior to the 
experimental conditions to ensure there was no learning effect or systematic bias 
within the main trials. During the first session participants were familiarised and fitted 
with a 25 kg weighted backpack (Infantry Bergen, Millar-tree, Bedford, UK) and 
subsequently completed 20 min exercise (6.5 km.h-1, 0% gradient) on a motorised 
treadmill (Woodway, PPS55 Med-I, Cranlea, UK), in temperate conditions (18°C; 
40% RH). The familiarisation sessions were not performed in hot conditions to avoid 
heat acclimation from repeated heat exposure in line with Coull et al. (2015). After 15 
min of seated recovery, participants then completed a 2.4 km self-paced time-trial 
carrying the 25 kg load on the same treadmill. The familiarisation employed in the 
present study was deemed appropriate to minimise any learning effects and is in line 
with Faghy and Brown (2014a) (load-carriage protocol) and Hope et al. (1998), Coull 
et al. (2015), Taylor et al. (2014), Watkins et al. (2014) (cognitive testing). 
 
The backpack load, walking speed and time-trial distance are in line with previous 
work on load-carriage performance, specifically related to military and occupational 
settings (Blacker et al., 2011, Faghy and Brown, 2014a, Faghy and Brown, 2014b). 
This specific protocol was designed and validated to closely reflect the physiological 
characteristics encountered in the military, enabling the assessment of deployment 
readiness and responses to relevant interventions (Faghy and Brown, 2014a). This 
protocol has shown good reproducibility as a measurement of load-carriage 
performance (interclass correlation (ICC): 0.85 and coefficient of variation (CV): 
10.53%) compared to the recommended level of acceptable error (Currell and 
Jeukendrup, 2008, Brughelli and Van Leemputte, 2013, Faghy and Brown, 2014a). 
The mass of the backpack load (25 kg) was equally distributed and worn in 
accordance with the manufacturer’s guidelines. The backpack was positioned 
individually to suit each participant by adjusting the shoulder and waist straps and this 
was recorded to the nearest mm to remain the same throughout both experimental 
trials. The second session involved full familiarisation with the protocol as described 
below in section 5.3.5, but in temperate conditions. Demonstration versions of the 
cognitive tests (described in detail in section 5.3.5) were performed before, during and 
after exercise in both familiarisation sessions.  
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5.3.4 Pre-Experimental Procedures 
Prior to the commencement of the main experimental trials, all participants completed 
a maximal oxygen consumption ( 𝑉𝑉Ȯ 2max) assessment on a motorised treadmill 
(Woodway, PPS55 Med-I, Cranlea, UK) using a standardised incremental protocol 
(ACSM, 2013). Participants were fitted with a heart rate (HR) monitor and suitably 
sized metalyser mask (Cortex, Cranlea, UK) and after a 5 min self-paced warm up, 
exercised until volitional exhaustion. Online breath-by-breath analysis (Cortex, 
Metalyser 3B, Cranlea) was used to determine ?̇?𝑉O2max after full calibration of the 
online system. Measures of HR and rating of perceived exertion (RPE) were recorded 
every minute for use as secondary criteria. For more details on other pre-experimental 
procedures and controls refer back to section 3.1.  
 
5.3.5 Experimental Procedures 
Participants attended the laboratory on two separate occasions for the two main trials 
(TYR and placebo) (Figure 5.1 for study schematic). See section 3.1 for details on 
experimental controls. Upon arrival at the laboratory, participants rested for 5 min in a 
seated position before completing the first cognitive test battery which included a 
vigilance, dual-task and simple reaction time test utilising the psychomotor evaluation 
software (PsychE) (Hope et al., 1998). The cognitive tests were all performed on a 
laptop and have previously been utilised to assess the effects of extreme 
environmental conditions on decision-making (Taylor et al., 2014, Watkins et al., 
2014) and the effects of TYR ingestion in the heat (Coull et al., 2015).  
 
The vigilance tests (2 min duration) required participants to focus on a laptop screen 
in which three-digit numbers appeared at a rate of 100 per min with an 8% duplication 
rate (Figure 5.2). Participants had to identify when the same number appeared twice 
in row by pressing the spacebar and were assessed on the amount of HIT (correct 
response), MISS (missed cue) and FALSE (false response) scores they achieved. The 
dual-task test (3 min duration) required participants to track a moving target with the 
mouse cursor and simultaneously respond to random stimuli (Figure 5.3). The 
percentage of time successfully on target (TRACKING) and stimuli responses (MISS 
and FALSE) were recorded (see Table 5.1 for descriptions of the vigilance and dual-
task cognitive tests). The third test measured reaction time and involved participants 
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holding down the spacebar until a random object appeared on the screen (between 1-
10 s), to which they reacted by releasing the spacebar and pressing a target key 
(numeric key 4-9) with the same finger (Figure 5.4). The test consisted of 20 stimuli 
presentations and for each response, thinking time (THINK) and movement time 
(MOVE) were recorded to an accuracy of 1 ms.  
 
All cognitive tests were laptop based and were employed in line with the descriptions 
provided by Hope et al. (1998). The tests were employed to enable a direct 
comparison with previous work from our research group, utilising the same cognitive 
test software (Coull et al., 2015) and for ease of administration and relevance to the 
military. For reliability, pre-supplement cognitive test values (vigilance, dual-task and 
simple reaction time) in TYR and PLA were compared to generate reliability 
statistics, which are reported within the results section. See statistical analysis for 
calculation methods and Table 5.2 for reliability statistics. 
 
 
 
 
 
 
 
 
 
Response Vigilance Dual-task 
HIT Correctly identifying a duplicate number N/A 
MISS Failing to identify a duplicate number Failing to identify a present icon 
FALSE Incorrectly identifying a duplicate number 
Incorrectly identifying an icon is 
present when it is not 
TRACKING N/A Ability to track a moving target (%) 
Table 5.1. Descriptions of each cognitive test response (HIT, MISS, FALSE and TRACKING) 
for vigilance and dual-task assessments (Coull et al., 2015). 
 49 
 
Figure 5.2. Screenshots of the PsychE software vigilance test. 
 
 
 
 
 
 
 
 
 
Figure 5.3. Screenshot of the PsychE software dual-task test being completed 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Image of the PsychE software simple reaction test being completed.  
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After the baseline cognitive test battery, participants then orally ingested a placebo 
[PLA (250 mL sugar free lemon squash) (Tesco, UK)] or TYR (same as PLA plus 
150 mg.kg body mass-1 TYR powder) (Nutricia Ltd, UK). They were instructed to 
consume this within 5 min, and then rest within the laboratory for 1 h before 
commencing the protocol. Participants were fitted with a HR monitor (Polar, FS1, 
Cranlea), rectal thermometer (Henleys, 400H and 4491H) inserted 10 cm past the anal 
sphincter, and skin thermistors (Grant, EUS-U-VS5-0, Wessex Power) attached to 
four skins sites; upper arm, chest, thigh and calf (Ramanathan, 1964). Subsequently, 
the following resting measures were recorded; HR, RPE [6-20 Borg scale (Borg, 
1982)], thermal sensation (TSS) [0-8 scale (Young et al., 1987)], readiness to invest 
mental (RTIME) and physical effort (RTIPE), core (Tre) and skin (Tsk) temperature 
and pre-exercise body mass (Digital Tanita Weighing scales, BWB0800, Allied 
Weighing, UK). The RTIME/RTIPE were measured on VAS and were used for a 
comparison between the current and a previous study (Coull et al., 2015). 
 
Approximately 1 h post TYR ingestion, participants then completed another cognitive 
test battery before entering the environmental chamber (T.I.S.S Services UK, 
Hampshire, UK), set at 40°C; 30% RH. Once inside the chamber, participants were 
fitted with the 25 kg backpack before commencing the 60 min load-carriage protocol, 
in which they were required to walk at a speed of 6.5 km.h-1 with a 0% incline (Faghy 
and Brown, 2014a). Halfway through the 60 min walk (at 30 min), participants 
completed further cognitive assessments (vigilance and simple reaction time only), 
while walking on the treadmill, via a custom-built laptop stand (see Figure 5.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Simulated military walk in the environmental chamber (a) and participant 
completing cognitive tests on a treadmill with custom built stand during familiarisation (b).  
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The 60 min walk was followed by 15 min seated recovery, in which participants 
removed the backpack and completed further cognitive assessments within the 
environmental chamber. During the recovery period in the first trial (either PLA or 
TYR), participants were provided with 1 L of water after completing the cognitive 
assessments and were instructed to drink this ad libitum. The total amount of water 
consumed was recorded and the same amount was provided in the second trial (either 
PLA or TYR), to ensure fluid intake was standardised. Participants then commenced a 
2.4 km time-trial with the 25 kg loaded backpack, which they were instructed to 
complete as fast as possible (Faghy and Brown, 2014a). On completion of the time-
trial, participants completed the final cognitive test battery before evacuating the 
chamber into a thermo-neutral room. Subsequently, a post-exercise body mass 
recording was obtained, and finally participants were provided with a drink and asked 
to remain seated in the thermo-neutral room until Tre returned to baseline. 
 
5.3.5.1 Measurements 
During the load-carriage protocol, physiological (HR), perceptual (RPE and TSS) and 
temperature (Tre and Tsk) measures were recorded at 10 min intervals. Specific data 
loggers were used to record Tre (Measurement Specialties, 4600, Henleys Medical) 
and Tsk (Grant, Squirrel Series, model 451, Wessex Power) and weighted mean Tsk 
was calculated from the temperatures recorded for all four skin sites using the 
Ramanathan (1964) equation where ‘t’ represents temperature:  
0.3(tchest + tarm) + 0.2(tthigh +tleg) 
Additionally, at 15 min intervals, RTIPE/RTIME and the temperature and humidity of 
the chamber were also recorded. During the entire protocol (60 min walk and 2.4 km 
time-trial) participants were unaware of the time elapsed and were only able to view 
the distance covered during the time-trial. Throughout the time-trial, participants 
communicated when they had reached certain distances (0.5, 1, 1.5, 2 and 2.4 km) to 
enable the researcher to record the physiological, perceptual and temperature 
measurements. In total, cognitive function was measured at five separate time points; 
pre-supplementation, pre-exercise, during exercise (30 min into load carriage protocol 
while walking on the treadmill), during the 15 min break and post time-trial. 
However, the dual-task test was not performed during exercise due to the difficulty 
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using a mouse while walking on the treadmill. Physical performance was assessed 
using the 2.4 km time-trial times recorded in both TYR and PLA conditions. Sweat 
loss was calculated from the difference in pre- and post-exercise body mass, after 
adjusting for fluid intake and urine loss (during the 15 min break). 
Note: Venous blood samples were taken in this study to assess serum TYR 
concentrations and LNAA ratio using standardise venepuncture technique (pre-
supplementation, pre-exercise and immediately after the last cognitive assessment). 
Analyses of these samples were due to be carried out at another institution in line with 
the amino acid analysis in experimental chapter 1, however due to time and specific 
other restraints this was not possible and thus data is not available to present within 
this thesis. 
5.3.6 Statistical analysis 
An a priori power calculation (G*Power 3) was used to determine the number of 
participants required for this study (n = 8) with an alpha level of 0.05 and statistical 
power of 99%, using data (time-trial completion times) from previous load-carriage 
research (Faghy and Brown, 2014a). Statistical analysis was completed using linear 
mixed models (IBM SPSS statistics for Macintosh, Version 20, Armonk, NY) to 
analyse mean differences in all variables between the two conditions (TYR and PLA). 
Where significance was obtained, Sidak post-hoc tests were used to locate significant 
pairs. Ninety-five percent confidence intervals (95% CI) were also presented where 
necessary. Two-tailed statistical significance was accepted at the p < 0.05 level. The 
reproducibility of the cognitive function tests (pre-supplementation baseline tests; n = 
8) was calculated using the change in mean, coefficient of variation (CV), intraclass 
correlation coefficient (ICC) and typical error (TE) utilising Microsoft Excel. 
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5.4 Results  
5.4.1 Cognitive function 
Linear mixed model analysis revealed that there was no systematic bias for the 
cognitive test measures. Reproducibility statistics for vigilance, dual-task and reaction 
time are reported in Table 5.2 (pre-supplementation resting values in TYR and PLA). 
Vigilance MISS and FALSE and dual-task FALSE statistics (ICC, CV and typical 
error (TE)) were found to be unreliable from the available data. 
 
 
 
5.4.1.1 Vigilance 
There was no significant main effect for condition for vigilance HIT scores between 
TYR and PLA (F1,63 = 0.22, p = 0.64). There was also no significant effect of time 
(F4,63 = 2.21, p = 0.08) or condition x time interaction (F4,63 = 1.89, p = 0.12). 
Similarly, there was no significant main effect for vigilance MISS scores (F1,63 = 0.09, 
p = 0.77) and no significant effect of time (F4,63 = 1.81, p = 0.14) or condition x time 
interaction (F4,63 = 1.96, p = 0.11). There was a significant effect of time for vigilance 
FALSE scores (F4,63 = 5.79, p < 0.001) with higher scores observed during the 
exercise bout (85% higher in TYR and 157% higher in PLA), compared to pre-
exercise scores (p = 0.01, 95% CI = -2.7- -2.1). However, there was no effect of 
condition (F1,63 = 0.79, p = 0.38) or condition x time (F4,63 = 1.01, p = 0.41). 
Variable P value ICC CV (%) TE (%) 
Vigilance: HIT 
 
0.90 0.87 13.90 0.48 
Vigilance: MISS 0.90 0.76 64.70 0.67 
Vigilance: FALSE 0.73 0.53 55.10 1.10 
Dual-task: TRACKING 0.94 0.50 7.80 1.15 
Dual-task: MISS 
 
0.72 0.70 10.90 0.25 
Dual-task: FALSE 
 
0.72 0.32 40.40 0.63 
Reaction time: THINK 
 
0.60 0.80 10.30 0.67 
Reaction time: MOVE 0.67 0.80 14.40 0.60 
Table 5.2. Reliability data for cognitive tests measured at rest. 
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5.4.1.2 Dual-task 
There was a significant effect of time for dual-task TRACKING scores (F3,49 = 8.34, p 
< 0.001). On average TRACKING accuracy (%) was significantly lower after the 60 
min bout of exercise (18% lower in TYR and 10% lower in PLA), compared to pre-
exercise scores (p = 0.01, 95% CI = 4.7-22.7%). However, there was no significant 
main effect of condition (F1,49 = 1.59, p = 0.21) or condition x time interaction effect 
(F3,49 = 0.91, p = 0.44). No significant main effect of condition was observed for dual-
task MISS scores (F1,49 = 2.10, p = 0.16) and there was similarly no effect of time 
(F3,49 = 1.46, p = 0.24)  or condition x time interaction (F3,49 = 2.15, p = 0.11). There 
was a significant effect of time (F3,49 = 6.68, p < 0.01) and a significant condition x 
time interaction effect (F3,49 = 6.58, p < 0.01) for dual-task FALSE scores but no 
significant main effect for condition (F1,49 = 2.66, p = 0.11). On average FALSE 
scores increased after exercise in the heat and specifically after the 60 min exercise 
bout, FALSE scores were significantly higher in TYR compared to PLA (p < 0.01, 
95% CI = 2-5). 
 
5.4.1.3 Simple reaction time 
A significant effect of time was observed for THINK time in the simple reaction test 
(F4,63 = 3.62, p < 0.01). On average THINK time was slowest during exercise with a 
19% increase in TYR and 29% increase in PLA from pre-exercise scores (p = 0.01, 
95% CI = 16.9-161.9 ms). However, there was no significant main effect of condition 
(F1,63 = 0.004, p = 0.95) or a significant condition x time interaction effect (F4,63 = 
0.30, p = 0.88). Similarly, there was a significant effect of time for MOVE time in the 
simple reaction test (F4,63 = 4.96, p < 0.01), but no significant main effect for 
condition (F1,63 = 0.07, p = 0.79) or condition x time interaction effect (F4,63 = 0.24, p 
= 0.92). On average MOVE time was slower immediately post time-trial (26% slower 
in TYR and 26% slower in PLA), compared to pre-exercise (p = 0.048, 95% CI = 
0.18-81.3 ms).  
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Response Condition 
Cognitive test score 
Pre-ingestion Pre-exercise 30 min 60 min Post TT 
Vigilance 
HIT 
TYR 
PLA 
10.6 ± 3.6 
10.5 ± 3 
10.1 ± 3.7 
10.1 ± 3.2 
11.0 ± 4.0 
8.8 ± 4.1 
9.4 ± 4.2 
10.6 ± 3.2 
11.6 ± 3.2 
11.6 ± 2.8 
Vigilance  
MISS 
TYR 
PLA 
4.4 ± 2.8 
4.5 ± 2.8 
5.3 ± 3.2 
4.8 ± 3.2 
4.0 ± 3.7 
6.1 ± 3.9 
5.8 ± 3.8 
4.3 ± 3.2 
3.4 ± 2.9 
3.8 ± 2.7 
Vigilance 
FALSE 
TYR 
PLA 
1.3 ± 0.9 
1.4 ± 1.2 
1.8 ± 1.7 
1.3 ± 1.0 
2.4 ± 2.1# 
3.6 ± 1.7# 
1.4 ± 1.3 
1.5 ± 0.8 
1.0 ± 1.8 
1.3 ± 0.7 
Dual-task 
TRACKING 
TYR 
PLA 
67.6 ± 6.5 
67.3 ± 6.8 
66.8 ± 6.6 
67.9 ± 5.4 
No test 
No test 
48.9 ± 19.3# 
58.4 ± 13.5# 
58.5 ± 19.5 
60.0 ± 12.0 
Dual-task  
MISS 
TYR 
PLA 
1.1 ± 0.4 
1.3 ± 0.5 
1.3 ± 0.5 
1.1 ± 0.4 
No test 
No test 
2.1 ± 1.4 
1.1 ± 0.4 
1.3 ± 1.2 
1.3 ± 2.4 
Dual-task 
FALSE 
TYR 
PLA 
0.5 ± 0.8 
0.3 ± 0.7 
0.4 ± 0.5 
0.6 ± 0.7 
No test 
No test 
3.8 ± 2.8*# 
0.6 ± 0.7# 
1.3 ± 2.4# 
2.1 ± 1.9# 
Simple reaction 
THINK (ms) 
TYR 
PLA 
428.6 ± 68.6 
411.4 ± 69.0 
402.9 ± 55.6 
391.7 ± 46.8 
480.3 ± 114.6# 
505.6 ± 192.0# 
447.8 ± 128.2 
449.7 ± 104.1 
429.0 ± 102.4 
456.6 ± 84.7 
Simple reaction 
MOVE (ms) 
TYR 
PLA 
145.1 ± 53.4 
153.5 ± 52.5 
155.5 ± 59.8 
156.4 ± 49.9 
186.1 ± 48.0 
168.8 ± 53.2 
198.4 ± 76.6# 
193.6 ± 75.1# 
196.1 ± 75.1# 
197.3 ± 67.0# 
Table 5.3. Cognitive test scores in TYR and PLA conditions for all time-points measured. Values 
are mean ± SD. *Significant difference between conditions and #over time (p < 0.05).  
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5.4.2 Time-trial performance 
No significant difference was observed in time-trial completion time (F1,14 = 547.9 , p 
= 0.74) between the TYR (19.78 ± 3.44 min) and PLA (20.29 ± 3.55 min) condition 
(Figure 5.6).  
 
 
 
 
 
 
 
 
5.4.3 Heart rate 
 
A significant effect of time (F13,189 = 159.16, p < 0.001) was observed for mean HR, 
with a mean increase of 127 b min-1 and 126 b min-1 from pre-exercise to immediately 
post the time-trial in TYR and PLA, respectively (p < 0.001, 95% CI = 93.4-159.9 b 
min-1) (Figure 5.7). However, there was no significant main effect of condition for 
mean HR (F1,189 = 5.84, p = 0.06) between TYR (156 ± 14 b min-1) and PLA (160 ± 
15 b min-1) and no significant condition x time interaction effect (F13,189 = 1.59, p = 
0.18). 
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Figure 5.6. Group mean time-trial completion times (min) in both TYR 
and PLA conditions. Values are mean ± SD.   
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5.4.4 Temperature measures 
There was a significant effect of time for mean Tsk (F13,189 = 96.16, p < 0.001), with 
increases during both bouts of exercise and a decrease during the rest period (Figure 
5.8a). Highest mean Tsk values were observed at the end of the 60 min exercise (36.8 
± 0.9°C in TYR and 37.0 ± 0.5°C in PLA). No significant main effect of condition 
was observed for mean Tsk (F1,189 = 3.1, p = 0.11) between TYR (35.7 ± 0.9°C) and 
PLA (36 ± 0.7°C) and there was no condition x time interaction effect (F13,189 = 0.19, 
p = 0.99). Similarly, there was a significant effect of time for mean Tre  (F13,189 = 
90.16, p < 0.001), with an increase during both bouts of exercise and a decrease 
during the rest period (Figure 5.8b). Peaks in Tre were observed both at the end of the 
60 min exercise bout and immediately post time-trial, however the highest Tre values 
were observed at then end of the time-trial (38.8 ± 0.4°C in TYR and 38.8 ± 0.5°C in 
PLA). No significant main effect for condition was observed for mean Tre (F1,189 = 
1.43, p = 0.23) between TYR (38.2 ± 0.4°C) and PLA (38.2 ± 0.4°C) and there was 
no condition x time interaction effect (F13,189 = 0.41, p = 0.97).  
Figure 5.7 Group mean heart rate (b min-1) responses in TYR and PLA 
during the 60 min walk, rest period and 2.4 km time-trial. Values are 
mean ± SD. #Significant differences over time (p < 0.05). 
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5.4.5 Subjective measures 
A significant effect of time was observed for mean TSS (F13,189 = 93.1, p < 0.001), 
with an increase throughout both bouts of exercise, reaching end values of  7 ± 1 in 
TYR and 7 ± 1 in PLA, indicating that participants felt ‘very hot’ to ‘unbearably hot’ 
(Figure 5.9a). No significant main effect for condition was observed in mean TSS 
scores (F1,189 = 1.35, p = 0.25) between TYR (6 ± 1) and PLA (6 ± 1) and there was 
no significant condition x time interaction effect (F13,189 = 0.62, p = 0.84). Similarly, 
Figure 5.8 Group mean weighted skin temperature (a) and mean core 
temperature (b) responses in TYR and PLA during the 60 min walk, rest 
period and 2.4 km time-trial. Values are mean ± SD. #Significant 
differences over time (p < 0.05). 
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there was a significant effect of time for mean RPE (F13,189 = 131.61, p < 0.001) as 
RPE values increased throughout both bouts of exercise but were highest on 
completion of the time-trial, reaching values of 19 on the Borg scale in both TYR and 
PLA (Figure 5.9b). There was no significant main effect of condition for mean RPE 
scores (F1,189 = 1.22, p = 0.27) between TYR (15 ± 2) and PLA (15 ± 1) and no 
significant condition x time interaction effect was observed (F13,189 = 0.96, p = 0.49). 
 
 
Figure 5.9. Group mean thermal sensation (TSS) (a) and rating of 
perceived exertion (RPE) (b) in TYR and PLA, during the 60 min walk, 
rest period and 2.4 km time-trial. Values are mean ± SD. #Significant 
differences over time (p < 0.05).  
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5.4.6 Effort scales 
A significant effect of time for mean RTIPE was observed (F7,105 = 38.41, p < 0.001), 
as on average RTIPE decreased by 77% and 75% from pre- to post-exercise in TYR 
and PLA, respectively (p < 0.001, 95% CI = 4.9-7.8) (Figure 5.10a). However, there 
was no significant main effect for condition (F1,105 = 0.69, p = 0.41) between TYR (5 
± 1) and PLA (5 ± 1) and no significant condition x time interaction effect (F7,105 = 
0.90, p = 0.51). Equally, a significant effect of time was observed for mean RTIME 
(F7,105 = 32.24, p < 0.001), with a 75% and 74% decrease from pre- to post-exercise in 
TYR and PLA, respectively (p < 0.001, 95% CI = 4.7-7.7) (Figure 5.10b). No 
significant main effect of condition was observed (F1,105 = 1.56, p = 0.22) between 
TYR (5 ± 1) and PLA (5 ± 1) and no significant condition x time interaction effect 
(F7,105 = 0.93, p = 0.65).    
5.4.7 Hydration status 
No significant difference was observed in pre-exercise urine osmolality (F1,14 = 0.01, 
p = 0.95) between TYR (141.3 ± 100 mOsm kg−1) and PLA (145 ± 114 mOsm kg−1). 
No significant difference was observed in mean sweat loss (F1,14 = 0.03, p = 0.87), 
which was calculated from pre- to post-exercise body mass measurements, between 
TYR (1.7 ± 0.3 L) and PLA (1.6 ± 0.5 L). 
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Figure 5.10. Group mean RTIPE (a) and RTIME (b) in TYR and 
PLA, during the 60 min walk, rest period and 2.4 km time-trial. 
Values are mean ± SD. #Significant differences over time (p < 0.05).  
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5.5 Discussion 
The aim of this experimental chapter was to investigate the effects of TYR on steady 
state exercise, cognitive function and 2.4 km time-trial performance in a hot 
environment (40°C), utilising the identified dose from the findings of experimental 
chapter 1. The main finding was that 150 mg.kg body mass-1 TYR ingested 1 h pre-
exercise did not significantly influence any aspect of cognitive function (vigilance, 
dual-task and simple reaction time), contrary to the primary hypothesis. In both 
conditions, a significant main effect of time (p < 0.01) was observed for FALSE 
scores (vigilance and dual-task), dual-task TRACKING scores and for simple reaction 
time, demonstrating declines in cognitive function both during and immediately after 
exercise-heat-stress from pre-exercise scores (Table 5.3). Furthermore, as expected 
TYR ingestion had no beneficial effect on physical performance, as time-trial time 
was similar in both conditions (Figure 5.6). Despite a large body of literature 
demonstrating that TYR is a useful ergogenic aid (Deijen et al., 1999, Lieberman et 
al., 2005, Mahoney et al., 2007, O'Brien et al., 2007, Tumilty et al., 2011, Kishore et 
al., 2013, Coull et al., 2015), the present findings are in accordance with two recent 
studies suggesting that 150 mg.kg body mass-1 TYR does not influence cognitive 
function and/or physical performance in hot environmental conditions (Watson et al., 
2012, Tumilty et al., 2014).  
 
Within humans the attainment of a state of ‘central fatigue’ via an intervention 
(exercise or otherwise) is problematic and debate still exists regarding the methods 
used to indicate whether such a state has occurred. Future work is evidently required 
to find and develop valid and reliable metrics to identify a state of ‘central fatigue’ in 
humans. The current protocol was employed on the basis that the combination of 
load-carriage (25 kg) exercise and extreme heat exposure (40°C) would create an 
ecologically valid and sufficiently demanding environment to alter central 
catecholamine neurotransmission. During acute stress, there is an observed increase in 
the activation of noradrenergic neurons in the frontal cortex, which release 
neurotransmitter as a response to stress (Deijen and Orlebeke, 1994). The continued 
release of neurotransmitter is fundamental in the ability to cope with stress, and thus 
as concentrations begin to deplete, aspects of cognitive function start to deteriorate 
(Kishore et al., 2013). Hence, the use of TYR to increase catecholamine synthesis is 
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believed to be useful in this state and has proved to be beneficial in previous studies 
reporting improvements in aspects of cognitive function (vigilance, working memory, 
tracking) and mood in stressful conditions (Neri et al., 1995, Deijen et al., 1999, 
Mahoney et al., 2007, O'Brien et al., 2007, Kishore et al., 2013, Coull et al., 2015). 
Conversely, in the present study this was not the case, as unexpectedly, TYR did not 
influence vigilance, dual-task or simple reaction time, despite the sound 
neurochemical basis for its use. This was despite observed impairments in cognitive 
function after the exercise-heat-stress (see Table 5.3), suggesting that the 
experimental protocol was sufficiently demanding, as anticipated. Moreover, in 
support of this, end HR (189.5 ± 4.2 v 197.9 ± 7.4 b min -1), RPE (18.8 ± 1.2 v 19.4 ± 
0.7) and TSS (7.3 ± 0.5 v 7.4 ± 0.4) values reached near maximum and post time-trial 
Tre was also high (38.8 ± 0.4 v 38.8 ± 0.5°C) in both TYR and PLA conditions 
respectively. 
 
Although the present protocol was physically demanding, it could be argued that the 
combination of multiple stressors experienced in previous military based studies 
(Banderet and Lieberman, 1989, Deijen and Orlebeke, 1994, Deijen et al., 1999, 
Mahoney et al., 2007, O'Brien et al., 2007) may have induced more severe stress-
related decrements in cognitive function and mood state. For example, in one study, 
military personnel endured a weeklong combat training course in which they were 
physically and emotionally stressed and also deprived of sleep and food (Deijen et al., 
1999). Such prolonged stress may have caused significant depletion in central 
catecholamine concentration and thus provision of exogenous TYR may be more 
likely to exert beneficial effects. It may be that exercise-heat-stress alone is not 
sufficient enough to manipulate central catecholamine activity to an extent whereby 
TYR is influential. However, as the military studies are mostly field based, it is 
difficult to compare these findings with the present laboratory controlled data. 
 
The present study utilised the exact same cognitive test software (PsychE) as a recent 
TYR investigation by Coull et al. (2015), who observed improvements in vigilance 
when exposed to a demanding soccer-simulation in a warm environment (25°C) (see 
Appendix G for full study details). The exercise-heat-stress experienced by 
participants in the present study was similar, if not more stressful than that of Coull et 
al. (2015), when comparing similar data such as end HR (175 b min -1 in TYR and 
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177 b min -1 in PLA), Tre (38.7°C in TYR and 39.0°C in PLA), RPE (16.6 in TYR and 
17.1 in PLA) and TSS (6.8 in TYR and 7.1 in PLA) (see above for data from the 
present study). Thus it is surprising that TYR did not have similar beneficial effects 
on cognitive function (improved vigilance). One possible explanation for this is that 
the cognitive tests employed within both studies (the present study and Coull et al. 
(2015)), are not necessarily 100% reliable according to the reliability statistics within 
the present thesis (Table 5.1). It appears from the available data that vigilance MISS 
and FALSE scores and dual-task FALSE scores are unreliable and therefore this must 
be taken into account when comparing findings between studies, as intra-individual 
and inter-individual differences in cognitive tests responses will influence the level of 
significance.  
 
Another possible reason for the opposing findings between the two studies may be the 
differing levels of psychological stress experienced. Since psychological stress is also 
associated with neurotransmitter depletion, small differences in the cognitive demand 
on the participants in each study may influence the level to which TYR has an effect 
(Jongkees et al., 2015). During the soccer simulation protocol utilised by Coull et al. 
(2015), participants had to constantly focus on specific audio and visual cues from the 
computer software, instructing them to change intensity, for a total of 90 min (see 
Appendix G methodology section for details). This added cognitive demand may have 
increased the psychological stress experienced by the participants. Whereas in the 
present investigation participants completed a 60 min walk with no added cognitive 
demand besides the 10 min cognitive test battery at the halfway point. Therefore, it 
could be speculated that the added psychological stress in the study by Coull et al. 
(2015) may have increased the potential for TYR to influence performance. The 
author acknowledges that blood measures of TYR, LNAA, DA and NA would have 
strengthened the study and allowed solid conclusions to be made regarding the 
opposing findings. However, this was not possible within the present investigation 
and is a potential avenue for future research in line with Kishore et al. (2013). 
 
Moreover, differences in the methodologies between these two studies may partially 
explain the opposing findings. For, example, the present study administered a single 
dose of TYR, compared to the double dose utilised by Coull et al. (2015), however as 
observed in experimental chapter 1, a double dose may not necessarily result in 
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significantly higher concentrations of circulating TYR. Furthermore, it is also worth 
noting that the supplement administered in the present study was sourced from a 
medical nutrition supplier (Nutricia Ltd), whereas the TYR used by Coull et al. 
(2015) was obtained from an online sport nutrition company (Myprotein.co.uk). Due 
to the known uncertainty regarding the composition of widely available nutritional 
supplements in the field, this is important to consider (Maughan, 2005, Watson et al., 
2012). The exact composition of both supplements is not exactly known, however 
HPLC analysis of the amino acid concentration revealed that the medical nutrition 
supplement was >98% pure, whereas the supplement sourced from the sport nutrition 
company only contained ~90% TYR (Coull et al., 2015). The difference between the 
two supplements may be a possible explanation for the observed findings, especially 
as two other studies who also used a verified form of TYR from a medical nutrition 
company (SHS International), failed to find improvements in cognitive function or 
exercise performance in the heat (30°C; 50% RH) (Watson et al., 2012, Tumilty et 
al., 2014). It is possible that the remaining 8% composition of the online sport 
nutrition supplement may contain an unknown substance(s) that could potentially 
influence performance (Maughan, 2005), however this is not clear from the analysis.  
 
The present study also assessed perceptual responses of effort using a readiness to 
invest effort scale (RTIPE and RTIME) in line with previous studies (Duncan et al., 
2012, Coull et al., 2015). Ratings of RTIPE and RTIME significantly decreased 
during exercise-heat-stress in both TYR and PLA trials (Figure 5.10), as anticipated. 
However, ingestion of TYR did not influence these ratings, conflicting the recent data 
(Appendix G) from (Coull et al., 2015). As TYR has consistently been shown to 
improve aspects of mood and motivation (discussed previously), it was predicted that 
TYR would improve RTIME and/or RTIPE. It must be noted that the scales used 
within the current study are not necessarily a valid and reliable measure of mood, 
however they enable immediate responses, appropriate for assessment during 
exercise. Retrospectively, the use of the well-established profile of mood states 
(POMS) questionnaire could have been used alongside (but not a replacement of) 
these perceptual measures for a pre-to post-exercise mood state comparison, similar to 
previous studies (Banderet and Lieberman, 1989, Mahoney et al., 2007, Piacentini 
and Meeusen, 2015).  
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As expected, TYR did not influence physical performance in the present study, with 
no difference in 2.4 km time-trial time between conditions. To date, only one study 
has observed a beneficial effect of TYR (Myprotein.co.uk) on physical performance, 
with an observed 15 ± 11% increase in exercise capacity in the heat (30°C; 50% RH), 
compared to placebo (Tumilty et al., 2011). As the TYR used in this study (Tumilty et 
al., 2011) was sourced from the same company as Coull et al. (2015) it may be 
assumed both supplements have a similar composition and thus these findings should 
be interpreted with care. Conversely, all other studies (including the present study) 
assessing the effects of TYR on exercise performance, have failed to demonstrate 
significant performance improvements in temperate (Strüder et al., 1998, Chinevere et 
al., 2002, Sutton et al., 2005) and hot environmental conditions (Watson et al., 2012, 
Tumilty et al., 2014, Coull et al., 2015). In temperate conditions, these findings are 
not surprising as under conditions that are not highly stressful, cerebral levels of TYR 
hydroxylase are saturated with substrate, thus supplementing with TYR should not, in 
theory, increase catecholamine synthesis (Lehnert et al., 1984, Foley and Fleshner, 
2008). However, during exercise-heat-stress there is a strong rationale for the use of 
TYR due to the observed depletion in neurotransmitter release during stress and the 
consequential reduction in motor control, arousal and motivation (Lehnert et al., 
1984, Lieberman et al., 2005). Tumilty et al. (2014) propose a possible mechanism to 
elucidate the lack of beneficial effects, suggesting that ingestion of TYR may have 
increased central NA activity and thus counteracted any influence on performance. 
This theory comes after one study demonstrated a reduction in exercise performance 
after ingestion of a NA reuptake inhibitor (reboxetine) in a hot environment 
(Roelands et al., 2008). As TYR is a general catecholamine precursor, this 
explanation is plausible, however further investigation into the central effects of TYR 
are required.  
 
There are several limitations within the present investigation, which may be 
considered for future research in this area. One obvious issue is the recruitment of 
recreationally active male volunteers, rather than military personnel. The fact that the 
participants had no prior experience with load-carriage or military based protocols 
may have confounded results. However, as all participants had rigorous 
familiarisation with the backpack and load-carriage protocol (see section 5.3.3), the 
influence of this issue was likely therefore minimised. Furthermore, the protocol 
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speed (6.5 km.h-1) and backpack mass (25 kg) was not individualised for each 
participant, thus the physiological stress may not have been equal which may have 
caused inter-individual differences in the dependant variables measured. The current 
protocol closely simulates training exercises and assessments used within the British 
Army and is similar to the Infantry Basic Combat Fitness Test (8 mile course at 15 
min per mile (6.4 km.h-1), carrying a 25 kg load) and Advanced Combat Fitness Test 
1 (2.4 km time-trial with 20 kg load) (Knapik and Reynolds, 2012, Faghy and Brown, 
2014a). Thus, to preserve the validity of the protocol in relation to military operations, 
it was not individualised and instead recruitment of a homogenous sample of 
participants (see section 5.3.1 for participant characteristics) was attempted, to 
minimise inter-individual variation.  
 
Finally, the cognitive test software utilised in the present study was laptop based and 
only measured certain aspects of cognitive function. Two of the tests also lacked 
reliability in some instances and thus the present results must be interpreted with care. 
It may also be that the software was not sensitive enough to reveal small 
improvements and thus this investigation would have benefitted from a more 
advanced assessment of cognitive function. For example, a recent study assessed the 
effects of TYR on cognitive function during passive heat-stress and used event related 
potentials to provide a neurophysiological method of examining higher cerebral 
function (Kishore et al., 2013). Other heat-based studies have utilised brain imaging 
techniques (fMRI and EEG) (Hocking et al., 2001, Sun et al., 2011, Liu et al., 2013) 
and the attention network test (Sun et al., 2011, Liu et al., 2013) to broadly assess 
higher levels of cognitive function and brain activity simultaneously. Future studies 
examining cognitive function should utilise these objective tools as they provide a 
reliable, quantifiable and non-invasive method of measuring the brain activity 
responsible for certain cognitive processes (Kishore et al., 2013). However, it must be 
noted that such advanced techniques may be difficult, if not impossible to implement 
during exercise. 
 
5.6 Conclusion 
In conclusion, the results of the present study demonstrate that load-carriage (25 kg) 
in a hot environment (40°C) significantly impairs aspects of cognitive function 
compared to pre-exercise measures and contrary to the experimental hypothesis 
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ingestion of 150 mg.kg body mass-1 TYR did not attenuate these decrements. 
Furthermore, TYR did not influence 2.4 km time-trial performance with similar 
completion times observed in both conditions, suggesting that under the conditions of 
the present study, TYR is not a useful ergogenic aid. Future research should aim to 
elucidate the central effects of TYR to enable a better understanding of its 
mechanistic properties.  
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CHAPTER 6: General Discussion and Conclusions 
6.1 General Discussion  
The aim of this thesis was to investigate the efficacy of TYR as an ergogenic aid by 
first assessing the pharmacokinetics of TYR ingestion and secondly examining the 
effect of the identified dose on physical performance and cognitive function in a hot 
environment (40°C), utilising a military based protocol (Faghy and Brown, 2014a). 
Experimental chapter 1 identified that a single dose of 150 mg.kg body mass-1 was 
sufficient to elevate serum TYR concentrations without the need for ingestion of a 
second dose, as seen previously (Mahoney et al., 2007, O'Brien et al., 2007, Coull et 
al., 2015). Furthermore, administration of this dose did not induce any side effects 
and thus was considered safe to ingest prior to a stressful exposure.  
Despite these findings, experimental chapter 2 demonstrated that ingestion of 150 
mg.kg body mass-1 TYR did not significantly influence any aspect of performance. 
This is surprising since heat-related declines in cognitive function were apparent, 
suggesting that the load-carriage protocol was physically demanding, however 
contrary to the primary hypothesis and findings from previous research (Banderet and 
Lieberman, 1989, Deijen et al., 1999, Mahoney et al., 2007, O'Brien et al., 2007, 
Kishore et al., 2013, Coull et al., 2015), TYR did not alleviate these decrements. 
Similarly, TYR did not influence physical performance as no differences were 
observed in response to steady state exercise (60 min walk) or 2.4 km time-trial 
performance time in the heat. This finding was to be expected as the majority of 
previous studies have also failed to observe any beneficial effect of TYR on aspects 
of physical performance in both temperate and hot environmental conditions. 
A number of possible reasons may explain the findings of the present investigation, 
however one particularly interesting issue has been highlighted within this thesis. The 
source of the TYR supplement administered in the present and previous studies may 
be of great importance when comparing findings. Of the studies that have reported the 
source of their TYR supplement, two studies have observed significant improvements 
in cognitive function (Coull et al., 2015) and exercise capacity (Tumilty et al., 2011) 
in the heat after ingestion of TYR from an online sport nutrition company 
(Myprotein). Whereas the studies that have utilised a TYR supplement sourced from 
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verified medical nutrition companies (including the present study) have failed to find 
any benefit of ingesting TYR, despite similar elevations in blood TYR concentrations 
(Watson et al., 2012, Tumilty et al., 2014). As previously discussed, this is important 
to consider due to the known uncertainty with widely available sport nutrition 
products (Maughan, 2005). However, further research into the composition of both 
supplements is required before assumptions can be made. 
 
6.2 Future Research Recommendations  
Several limitations have been highlighted in relation to the investigations of 
experimental chapter 1 and 2 (see relevant chapter for experimental limitations), 
which should be considered for future research. In light of these limitations, it is 
recommended that future studies utilise strictly medical grade TYR supplements that 
have been sourced from verified medical nutrition suppliers to minimise the risk of 
contamination and to enable study findings to be easily compared. Furthermore, due 
to the known confounding factors that can influence cognitive function, simply 
employing basic cognitive test batteries is no longer sufficient enough to draw 
confident conclusions. Therefore, to elucidate the mechanistic action of TYR and 
heat-stress in general, the use of advanced brain imaging techniques in tandem with 
intuitive cognitive testing (e.g. attention network test) are encouraged to provide 
reliable, object measures of high-level cerebral activity.  
6.3 Overall Conclusion 
In summary, the findings presented within the present thesis provide useful 
pharmacokinetics data of the most commonly administered doses of TYR within the 
literature. However, despite observing marked elevations in serum TYR 
concentrations, the present findings demonstrate that 150 mg.kg body mass-1 TYR had 
no beneficial effect on any aspect of cognitive function or physical performance. 
Therefore, this thesis provides further evidence to suggest that TYR does not 
influence physical performance as currently only one study has observed a beneficial 
effect to date. Conversely, as the majority of previous literature has demonstrated 
improvements in cognitive function after TYR ingestion, further research is required 
in this area before TYR is discounted as an ergogenic aid.  
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CHAPTER 8: Appendices 
Appendix A 
 
Information to Participants 
 
Study Title: 
Tyrosine Ingestion and its Effects on Cognitive Function and Load-Carriage Performance in the Heat 
 
Lead Researcher: Nicole Coull BSc (Hons) 
Supervisor: Dr. Lee Taylor, Ph.D 
2nd Supervisor: Dr. Bryna Chrismas, Ph.D  
 
Dear Participant, 
 
Thank you for showing an interest in participating in the study. Please read this information sheet 
carefully before deciding whether to participate. If you decide to volunteer we thank you for your 
participation. If you decide not to take part there will be no disadvantage to you of any kind and we 
thank you for considering our request. 
 
What is the aim of the project? 
The purpose of the study is to investigate the effects of an acute dose of tyrosine (a non-essential 
amino-acid, naturally produced by the body) on serum levels of tyrosine and other large neutral amino 
acids in the blood. This study is being undertaken as part of the requirements of MSc by Research 
(MRes) degree at the University of Bedfordshire. 
 
What type of participant is needed? 
Recreationally active males aged between 18 and 30 years old. 
 
What will participants be asked to do? 
The participant will be required to attend the University of Bedfordshire laboratories on 5 separate 
occasions.  
 
Study 1 (1 day): Visit 1 will involve baselines measures including height, weight and baseline blood 
samples taken. The participant is then required to consume the first dose of tyrosine/control depending 
on their allocation to either group 1 (CON; no tyrosine), group 2 (LOW; 2 doses of 75 mg/kg) or group 
2 (HIGH; 2 doses of 150 mg/kg) and remain in the lab for further blood samples. Four hours post 
ingestion of the first dose of tyrosine, participants will consume the second dose. Participants will then 
rest for the remainder of the session, having blood samples taken every hour for 4 hours after ingestion 
of the second dose. During the time in the laboratory, participants will consume a set breakfast and 
lunch (cornflakes and semi-skimmed milk) provided as part of the study to control the intake of 
tyrosine within their food. On the day prior to the trial they will consume their normal diet and record 
this in a food diary. Participants will then fast from 9pm until the morning of the trial. 
 
 
Study 2: Visit 2-5 will involve 2 familiarisation sessions in which participants will complete shortened 
bouts of the 6.5 km/h march and demo versions of the cognitive tests at rest and while walking on the 
treadmill in temperate conditions (20 °C) to accustom them to the protocol and to minimize a learning 
effect. A time trial (2.4k) will also be performed during familiarisation to accustom participants to self-
paced treadmill exercise. A weighted backpack (25kg) will be worn during familiarisation and the main 
trials to simulate occupation settings. 
As with study 1, participants will complete food diaries on the day before each experimental condition 
to then replicate on the subsequent visit. On the day of testing, participants will ingest the dose of TYR 
or PLA (150 mg/kg TYR or sugar free lemon squash for placebo) and rest in the laboratory for 1 hour 
prior to beginning the exercise protocol. Baseline measures will be taken (height, mass, urine and blood 
samples). Participants will be required to insert a pre-prepared rectal thermistor. Skin thermistors will 
then be applied to the participants at 4 sites as well as a heart rate monitor. After the necessary safety 
measures have been applied and the participant has rested for 5 min in a thermal neutral room (~18 oC), 
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the participant will then enter the environmental chamber (40 oC; 30% RH). Participants will then 
complete the load carriage protocol (60 min) followed by a 15 min rest period and then a 2.4 km time 
trial on the treadmill (40 oC; 30% RH) wearing a 25kg weighted backpack. Rectal temperature, skin 
temperature, heart rate, ratings of perceived exertion (Borg, 1982) and thermal sensation will be 
recorded every 5 min throughout the protocol and rest period to ensure the participants safety is not 
compromised (see potential risks for a detailed explanation). Cognitive function will also be measured 
before, during and after exercise on a computer-based software. Blood samples will be taken pre-
exercise, during the 15 min rest period and after the time-trial via venepuncture. 
 
What are the possible risks of taking part in the study? 
The ingestion of tyrosine can cause side effects, such as headaches, heartburn, joint pain, seriously 
upset stomach or an allergic reaction; however these are very uncommon and if any of these symptoms 
occur, testing will be immediately stopped and the participant will receive medical help. The doses of 
tyrosine used in this study have previously been used in the University of Bedfordshire laboratories and 
have caused no harm to any participant and we consider the doses to be safe to ingest. If you have, or 
if any of your family members have a history of hyperthyroidism (overactive thyroid) or a 
condition called Grave’s disease then you should inform the researcher, as it is not safe for you to 
consume tyrosine supplements. Also if you are taking medication for thyroid hormone or taking 
levodopa then tyrosine is not recommended.  
 
There are also risks associated with exercising in the heat such as heat stroke and exertional heat 
illness, however these are very uncommon and will be minimized when carrying out the correct safety 
measures. Furthermore, to monitor core temperature a rectal thermometer must be inserted which may 
be uncomfortable or cause anaphalactoid shock, this is also very rare and should this happen, first aid 
will be provided immediately. Do not be alarmed after reading the possible risks of this study as these 
are very rare and the researcher is fully aware of all the possible risks (and fully first aid trained) and 
the participant will be in a safe environment when testing in the laboratory.  
 
 
What if you decide you want to withdraw from the project? 
If at any stage you wish to leave the project, then you can. There is no problem should you wish to stop 
taking part and it is entirely up to you. There will be no disadvantage to yourself should you wish to 
withdraw. 
 
What will happen to the data and information collected? 
Everyone that takes part in the study will receive their own results for the tests that they complete. All 
information and results collected will be held securely at the University of Bedfordshire and will only 
be accessible to related University staff. Results of this project may be published, but any data included 
will in no way be linked to any specific participant. Your anonymity will be preserved. 
 
What if I have any questions? 
Questions are always welcome and you should feel free to ask myself, Nicole Coull or Dr. Lee Taylor 
(supervisor) any questions at anytime. See details below for specific contact details. 
 
Should you want to participate in this study then please complete the attached consent form, which 
needs to be returned before commencing the study. 
 
This project has been reviewed and approved by the Ethics Committee of the Department of Sport and 
Exercise Sciences. 
 
Many Thanks,  
 
Nicole Coull BSc (Hons)    Dr. Lee Taylor    
Tel: 07429096867                                                       Email: Lee.taylor@beds.ac.uk  
Email: Nicole.coull@study.beds.ac.uk   
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Appendix B 
 
CONSENT FORM 
 
TO BE COMPLETED BY PARTICIPANT  
 
 
Name of participant:………………………… Date:……………………… 
 
I have read the Information Sheet concerning this project and understand what is required of me as a 
participant. All my further questions have been answered to my satisfaction. I understand that I am free 
to request further information at any stage. 
 
I know that: 
 
• My participation in the project is entirely voluntary and I am free to withdraw from the project 
at any time without disadvantage or prejudice.  
 
• I will be required to attend 5 sessions to complete the project. 
 
As part of the study I will have to: 
 
• Ingest a safe acute dose of tyrosine (150 or 300 mg/kg). 
 
• Have several blood samples taken to assess serum tyrosine levels via venepuncture and 
cannulation. 
 
• Record 24-hour food diaries and replicate these when required. 
 
• Consume a fixed diet of cornflakes and semi-skimmed milk. 
 
• Have my body fat assesses via the Bod Pod. 
 
• Exercise in heated conditions, complete cognitive tests and have physiological measures taken 
throughout the trials. 
 
• Wear a 25 kg weighted backpack during the exercise protocol. 
 
• Insert a rectal thermometer to monitor core temperature for the purpose of the study and for 
your own safety. 
 
 
I am aware of any risks that may be involved with the project. 
 
All information and data collected will be held securely at the University indefinitely. The results of 
the study may be published by anonymity will be persevered. 
 
 
 
 
Signed:…………………………. 
 
 
 
 
 
 
 
 
 80 
Appendix C 
 
BLOOD ANALYSIS – Participant Screening Form 
 
Please read the following: 
 
a. Are you suffering from any known active, serious infection? 
b. Have you had jaundice within the previous year? 
c. Have you ever had any form of hepatitis?  
d. Have you any reason to think you may be HIV positive? 
e. Have you ever been involved in intravenous drug use? 
f. Are you a haemophiliac? 
g. Is there any other reason you are aware of why taking blood might be  
    hazardous to your health?  
h. Is there any other reason you are aware of why taking your blood might be  
    hazardous to the health of the technician? 
 
 
Can you answer Yes to any of questions a-g? Please tick your response in the box below: 
       
Yes   No  
 
 
 
Small samples of your blood (from finger or earlobe) will be taken in the manner outlined to you by the 
qualified laboratory technician. All relevant safety procedures will be strictly adhered to during all 
testing procedures (as specified in the Risk Assessment document available for inspection in the 
laboratory). 
 
  I declare that this information is correct, and is for the sole purpose of giving the researcher guidance 
as to my suitability for the test.  
 
    Name  ………………………………………  
 
   Signed  ………………………………………  
      
   Date  ……………………………………… 
 
  If there is any change in the circumstances outlined above, it is your responsibility to 
  tell the person administering the test immediately. 
 
 
This Blood Sampling Form will be held in a locked filing cabinet in the Department of Sport and 
Exercise Science laboratories at the University for a period of one-three years. After that time all 
documentation will be destroyed by shredding. 
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Appendix D 
 
Risk Assessment Questionnaire 
 
 
Name:………………………………      Date:………………… 
 
 
Please read the following carefully and answer as accurately as possible. The questions are designed 
solely to determine whether the proposed protocol is safe for you. Your answers will be treated as 
strictly confidential. If you have any doubts or difficulties with any of the questions please contact the 
researcher. 
 
 
1. Are you allergic to dairy, corn or soybeans (ingredients in cornflakes)? 
If so please state below. 
 
              YES  ……………………………..               NO 
 
2. Do you have allergies to tyrosine? 
 
YES                    NO 
 
3. Do you have any medical conditions related to thyroid problems? (E.g. overactive thyroid or 
Grave’s disease). 
 
              YES                    NO 
 
4. Do you know of any family members who you have any medical conditions related to thyroid 
problems? (E.g. overactive thyroid or Grave’s disease). 
 
       YES                    NO 
 
5. Do you have Phenylketonuria (PKU)? 
 
       YES                    NO 
 
6. Do you currently take any medication or supplements? If yes, please specify. 
 
       YES                    NO 
 
7. Is there any issue not raised that may mean that it is not safe for you to take tyrosine? Please 
state below. 
            
              YES                    NO 
 
 
I have completed the questionnaire to the best of my knowledge and any questions that I have raised 
have been answered to my full satisfaction. 
 
 
 
Signed:…………………………. 
 
 
 
 
 
 
 82 
Appendix E 
 
 
Participant reminders prior to your trial – Please read carefully 
 
IT IS IMPORTANT YOU FOLLOW THESE STEPS OR YOUR RESULTS WILL BE 
INVALID 
 
- Please do not exercise in the 24 hours leading up to your trial. 
 
- Please do not consume alcohol or caffeine for the 24 hours leading up to your trial. 
 
- On the day before your lab visit, record your food and drink consumption (24 hours) on the 
food diary provided – ensure you eat meals that you would like to replicate. 
 
- VISIT 1 ONLY:  Please do not eat or drink anything other than water after 9pm on the day 
before your lab visit. 
 
- Drink at least 500 mL of water on the morning before all visits to ensure you are hydrated. 
 
- Please wear the same clothing/trainers on all laboratory visits. 
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Appendix F 
 
 
Pre-test questionnaire 
 
 
Honestly answer these few questions before performing the experimental tests. 
 
 
Name: ………………………………. 
 
 
• Have you consumed alcohol or caffeine in the last 24 hours? 
 
YES            NO 
 
 
• Have you taken part in exhaustive exercise in the last 24 hours? 
 
YES            NO 
 
 
• Have you completed and brought with you a 24 hour food diary? 
 
YES            NO 
 
 
• Have you ingested any supplements in the last 4 weeks (including protein, BCAA, caffeine 
supplements etc.)? 
 
      YES            NO 
 
 
• Approximately how many hours of sleep did you get last night
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Appendix G - Previous TYR work conducted by our research group published in 
European Journal of Applied Physiology (Coull et al., 2015). 
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Appendix H 
 
Screenshot of MSSE publication related to this thesis – full text PDF is currently 
unavailable due to proofing process 
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Appendix I 
 
Power calculation for experimental chapter 1 
 
